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Preface
Epigenetic changes are heritable and reversible modifications that significantly 
affect gene expression without any change in DNA sequence. Epigenetic mecha-
nisms include DNA methylation, imprinting, chromatin remodelling via histone 
modifications, and the production of specific non-coding RNA. The epigenetic 
signature is remodelled during the lifespan as a direct consequence of both environ-
ment and lifestyle. Therefore, health or disease status strongly depends on epigen-
etic marks. In addition, the epigenetic signature of gametes and parental experience 
may cause transgenerational epigenetic inheritance, thus affecting offspring health. 
Lastly, emerging evidence reveals that epigenetic marks, and in particular circulat-
ing non-coding RNAs, represent upcoming biomarkers for the prevention, diagno-
sis and treatment of diseases.
This book summarizes the current knowledge in the field of epigenetics in five 
chapters. Chapter 1 provides a brief introduction to epigenetics and is followed 
by a study on epigenetics in plants (Chapter 2) and three chapters concerning 
epigenetics in health and disease: cancer (Chapter 3), the photoperiodic system 
(Chapter 4) and aging (Chapter 5).
Chapter 2 by Drs. Singroha and Sharma describes the epigenetic regulation of the 
plant genome, focusing on the epigenetic modifications in plants under abiotic 
stress.
Environmental factors and lifestyle both affect epigenetic marks. Thus, Chapter 3 
by Dr. Tobias et al. analyses the role of microRNAs in cancer and cachexia, pointing 
out the possible contribution of physical activity to tumor regression.
Chapter 4 by Dr. Haim et al. describes the consequences of artificial light at night 
and the links between chasing darkness away and epigenetic modifications.
Lastly, Chapter 5 by Dr. Mutirangura presents an interesting hypothesis for aging 
based on genome-wide hypomethylation. Such a condition may cause genomic 
instability and aging-associated disease phenotypes, thus explaining how the DNA 
of elderly people is prone to damage.
Taken together, the chapters in this book target a wide audience of basic and clinical 
scientists, teachers and students interested in gaining a better understanding of 
epigenetics.
Rosaria Meccariello
University of Naples Parthenope,
Italy
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In 1940 the developmental biologist Conrad H. Waddington firstly used the 
term “epigenetics” to describe “the interaction of genes with their environment, which 
bring the phenotype into being” [1]. Two years later, Conrad Waddington pointed out 
that “It is possible that an adaptive response can be fixed without waiting for the occur-
rence of a mutation” [2]. Thus, epigenetic modifications are heritable and reversible 
modifications that significantly affect gene expression without any change in the 
nucleotide sequence of DNA [3].
2. Molecular mechanisms
Classically, epigenetic mechanisms include (i) the methylation of DNA, (ii) the 
imprinting, (iii) the remodeling of chromatin, and (iv) the production of noncod-
ing RNA (ncRNA) [4, 5].
The methylation of DNA usually occurs at the 5-position of DNA cytosine 
(5mC) in the CpG islands located within the promoter region of specific genes; such 
a modification inhibits both the binding of transcription factors to DNA and affects 
the recruitment of proteins involved in chromatin remodeling [6, 7], thus causing 
gene silencing.
Genomic imprinting is a DNA methylation-dependent phenomenon, occurring 
during embryogenesis; it causes genes to be expressed from a parent of origin-
specific manner [8] and specifically interests at some genetic loci.
Nuclear DNA is structured in chromatin, an instructive DNA scaffold that can 
respond to external cues regulating DNA activity, composed of histone and nonhis-
tone proteins [9]. Euchromatin, which is the transcriptionally active region of the 
DNA, represents the loosely folded part of the chromatin; heterochromatin, which 
is a transcriptionally poorly active region of the DNA, represents the tightly folded 
part of the chromatin [10]. Therefore, the transcription rate of genes is strongly 
affected by dynamic chromatin remodeling. In this respect, posttranslational 
modifications of histone tails like methylation and acetylation play critical roles, 
by affecting either the affinity of transcriptional factors for gene promoter region 
or the recruitment to chromatin of nonhistone protein, thus disturbing chromatin 
contacts [10]. Histone tail acetylation usually promotes the transcription and is a 
feature of euchromatin; by contrast, histone tail methylation has usually an inhibi-
tory role for transcription and is a feature of heterochromatin.
The family of ncRNA includes a large set of RNAs like the well-known 
microRNA (miRNA) or the less known long noncoding RNA (lnRNA) and tRNA 
fragments (tRF) among others [11]. NcRNAs are involved in the control of gene 
expression and in the regulation of many biological functions in several tissues; 
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their expression rate is affected by environmental cues; thus, their expression rate 
changes in health and disease. Furthermore, the detection of ncRNA in biological 
fluids makes them a possible epigenetic biomarker for the prognosis, the diagnosis, 
and the treatment of diseases [12–14].
Thus, an epigenetic machinery comprising various writers, readers, and erasers 
that have unique structures, functions, and modes of action like the de novo and 
maintenance DNA methyltransferases, histone acetyltransferases, deacetylases, 
methyltransferases and demethylases, or the ncRNA biosynthetic pathways has 
been identified in living organisms [13]. However, additional epigenetic mecha-
nisms such as the delivery among tissues of epigenetic marks within extracellular 
vesicles, exosomes, or microvesicles are starting to emerge, providing evidence of 
upcoming communication pathways in which the products of specific cell types 
may affect the expression rate of specific RNAs in target tissues [15–17].
3. Epigenetics in health and disease
In mammals, epigenetic signature is firstly defined in the embryo [18, 19], but 
this mark is deeply remodeled during the life course as a direct consequence of 
environmental cues and lifestyle which includes diet, stress, pollutants, smoking, 
endocrine-disrupting chemicals, physical activity, sedentary life, etc. Therefore, 
genome activity is epigenetically modulated under exogenous influence, and the 
environment-dependent changes in gene activity stably propagate from one genera-
tion of cells to the next one. Epigenetic changes impact genome functions, thus 
affecting health and disease status and also behavior; aging-related diseases, cancer, 
immunity and related disorders, obesity, metabolic disorders, infertility, and 
cardiovascular and neurological diseases represent only few examples of environ-
mentally dependent diseases, and the literature in the field is growing up day by day 
[20–35].
Individual health or disease status strongly depends on epigenetic marks, but 
“parental experiences” may be epigenetically transmitted to the offspring, thus 
causing trans-generational epigenetic inheritance and affecting offspring health. 
Such a process requires the transmission of epigenetic marks through gametes 
and influences fertilization, embryo development, embryo gene expression, and 
phenotype [36]. Particularly interesting is the possibility that spermatozoa may use 
ncRNAs as carrier of paternal experiences, thus providing an “epigenetic memory” 
capable of affecting embryo development and health with consequences on adult 
offspring phenotype [13, 32, 33].
4. Conclusions and future perspectives
Taken together, both environment and lifestyle deeply affect DNA functions, 
and their influence may be transmitted to the next generations with consequences 
on health status. However, experimental data point out that epigenetic marks, and 
in particular circulating ncRNAs, may represent upcoming biomarkers for the 
prevention, the diagnosis, and the treatment of diseases, due to the great potential 
laying in developing epigenetic therapies [37–39].
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Plants face a plethora of biotic and abiotic stresses ranging from extreme tem-
peratures to salinity, drought, nutritional deficiencies, chemical toxicity, and patho-
gen attacks. As a consequence, plants have acquired several sophisticated regulatory 
mechanisms that allow them to cope with such adverse conditions. Epigenetic 
regulation plays a key role in the mechanisms of plant response to the environment, 
without altering DNA sequences. Epigenetics refers to heritable alterations in 
chromatin architecture that do not involve changes in the underlying DNA sequence 
but alter gene expression through DNA methylation or histone modifications. 
The epigenetic regulation of the plant genome is a highly dynamic process that 
fine-tunes the expression of a pertinent set of genes under certain environmental 
or developmental conditions. Over the past two decades rapid advancements in 
the field of high throughput sequencing unveil epigenetic information at genome 
wide level in various plant species. In view of the adverse effects of global climatic 
change, utilizing epigenetic differences for developing improved crop varieties is of 
paramount importance.
Keywords: histone modification, DNA methylation, abiotic stress, chromatin
1. Introduction
Plants being sessile organisms are being constantly challenged by various biotic and 
abiotic stresses. In order to adapt themselves to the changing environments they need 
constant changes at molecular level. These efficient and effective controls are provided 
by epigenetic regulations which improve the survivability of plants by increasing their 
tolerance toward stress [1, 2]. It is now evident that heritable phenotypic variation does 
not need to be based on DNA sequence polymorphism [2, 3]. These epigenetic regula-
tions involve different chemical modifications at molecular level that influence gene 
expression. Epigenetic as defined by Conrad Waddington, is “the study of mitotically 
and/or meiotically heritable changes in gene function that cannot be explained by 
changes in DNA sequence” [4]. Today epigenetic refers mainly to the changes that 
do not relate to the changes in DNA sequence but to chemical modification that can 
be inherited from one generation to the next [5, 6]. Three types of epigenetic regula-
tory mechanisms viz. DNA methylation, histone modification and RNA interference 
(RNAi) are exploited by plants in order to survive adverse conditions.
DNA methylation is a chemical modification, catalyzed by cytosine methyl-
transferases which involves addition of a methyl group in a DNA sequence onto the 
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Various types of epigenetic modifications under stress conditions.
cytosine residue in a sequence specific manner, primarily within CpG dinucleotide 
[7, 8]. The added methyl group provides platform for attachment of various protein 
complexes that modifies the histone scaffolds resulting in altered gene expression.
In eukaryotic nuclei DNA is organized in the form of nucleosome where it 
is wrapped around by histone proteins. Histones comprise a family of highly 
conserved globular proteins whose N-terminal tails are exposed on the surface of 
the nucleosome octamer for chemical modifications. Histones offer a wealth of 
post-translational modifications (PTMs) that physically regulate the accessibility 
of the transcriptional machinery to certain genomic regions, making loci more or 
less permissive for transcription [9]. Histone modifications include acetylation, 
methylation, sumoylation, ubiquitination and phosphorylation of histone proteins. 
Acetylation and phosphorylation are mostly associated with induced gene expres-
sion while on the other hand modifications like sumoylation and biotinylation 
represses gene expression [10, 11]. Such modifications not only impinge on DNA 
accessibility, but also on the recruitment of specific proteins involved in several 
processes, including transcription, DNA replication and repair. Histone proteins 
are not only modified, but can also be replaced by histone variants with different 
physical properties, or released, in order to allow gene expression [12].
In epigenetic cross-talks diverse classes of noncoding RNA (e.g., small RNAs and 
long noncoding RNAs) can also modify chromatin structure and silence transcrip-
tion through formation of RNA scaffolds mediating the recruitment of histone 
and DNA methyltransferases [13]. RNAi is a sequence specific gene regulation 
mechanism that acts as a barrier against viruses but also regulates gene expression. 
In plants RNA interference pathways are mediated by siRNA, miRNA and lncRNA 
(long non coding RNA). These RNAs are synthesized as 20–30 nucleotide, single 
stranded molecules from double stranded RNA precursors.
Activation of one or more of these pathways results into changes in chroma-
tin architecture and impacts gene expression. Open chromatin form or closed 
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chromatin conformation is associated with gene activation or silencing respectively 
and governs the onset of gene expression in cells under different developmental 
or environmental stimuli [14–16]. Transitions from open to close and crosstalk 
between different epigenetic mechanisms are vital to ensure proper cell function 
at different developmental stages and under abiotic stress conditions [17–19]. 
Different types of epigenetic modifications under abiotic stresses have been pre-
sented in Figure 1.
In the recent years, numerous studies performed toward the characterization 
of the epigenomic regulation of stress responses in plants have added to our under-
standing of how diverse abiotic stresses affect chromatin modifications, with their 
respective transcriptional and physiological implications.
2. Different types of epigenetic modifications
2.1 DNA methylation modification
DNA methylation arises as a result of addition of a methyl group to the nitrog-
enous base in the DNA strand in a sequence specific manner. DNA methylation 
occurs at the fifth carbon position of a cytosine ring. Methylation of cytosine leads 
to the generation of 5-methyl cytosine. On the basis of the target sequence, meth-
ylation is classified either as symmetrical or asymmetrical methylation. CG and 
CHG methylation are termed as symmetrical and CHH methylation as asymmetri-
cal. In plants DNA methylation occurs in all three sequence contexts; the symmetric 
CG and CHG context and asymmetric CHH (H = A, C or T) context [20]. Plants 
methylate only some genes and this methylation is usually restricted to CGs located 
within the gene body while Transposable Element sequences tend to be methylated 
at most of their CG, CHG, and CHH sites. Methylation in transposable elements 
and promoter region of a gene leads to silencing on the other hand methylation 
inside gene body induce gene expression [21]. Thus DNA methylation results into 
following (i) methylcytosines in the gene body play an important role in regulating 
the gene expression and (ii) methylcytosines in repetitive sequences (transposable 
elements), are thought to prevent repetitive sequences from compromising normal 
genome function [20, 21]. Increased methylation of genomic DNA down regulates 
gene expression. Down regulated gene expression enable the plants to conserve 
energy for the sake of biotic or abiotic stress. In contrast, the reduction in methyla-
tion of resistance-related genes favors chromatin activation and the expression of 
novel genes, which provides long-term or permanent resistance for stress.
2.2 Histone modifications in plants
In addition to DNA methylation, histone N-terminal tail modifications consti-
tute an attractive area in epigenetics [22]. Plants contain several histone variants 
and enzymes that posttranslationally modify histones and influence gene regula-
tion. Application of chromatin immunoprecipitation followed by deep sequencing 
has given insight into the genome-wide distribution of histone variants and histones 
bearing different posttranslational modifications [22, 23]. Histone proteins are 
wrapped around DNA and forms a highly compact structure called nucleosome. 
Nucleosomes are composed of histone octamers that comprise two copies each of 
H2A, H2B, H3, and H4. A total of 147 base pair of DNA sequence is wrapped around 
the histone core. The N termini of histone proteins called N terminal tails undergo 
various chemical modifications like methylation or acetylation. Such histone modi-
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standing of how diverse abiotic stresses affect chromatin modifications, with their 
respective transcriptional and physiological implications.
2. Different types of epigenetic modifications
2.1 DNA methylation modification
DNA methylation arises as a result of addition of a methyl group to the nitrog-
enous base in the DNA strand in a sequence specific manner. DNA methylation 
occurs at the fifth carbon position of a cytosine ring. Methylation of cytosine leads 
to the generation of 5-methyl cytosine. On the basis of the target sequence, meth-
ylation is classified either as symmetrical or asymmetrical methylation. CG and 
CHG methylation are termed as symmetrical and CHH methylation as asymmetri-
cal. In plants DNA methylation occurs in all three sequence contexts; the symmetric 
CG and CHG context and asymmetric CHH (H = A, C or T) context [20]. Plants 
methylate only some genes and this methylation is usually restricted to CGs located 
within the gene body while Transposable Element sequences tend to be methylated 
at most of their CG, CHG, and CHH sites. Methylation in transposable elements 
and promoter region of a gene leads to silencing on the other hand methylation 
inside gene body induce gene expression [21]. Thus DNA methylation results into 
following (i) methylcytosines in the gene body play an important role in regulating 
the gene expression and (ii) methylcytosines in repetitive sequences (transposable 
elements), are thought to prevent repetitive sequences from compromising normal 
genome function [20, 21]. Increased methylation of genomic DNA down regulates 
gene expression. Down regulated gene expression enable the plants to conserve 
energy for the sake of biotic or abiotic stress. In contrast, the reduction in methyla-
tion of resistance-related genes favors chromatin activation and the expression of 
novel genes, which provides long-term or permanent resistance for stress.
2.2 Histone modifications in plants
In addition to DNA methylation, histone N-terminal tail modifications consti-
tute an attractive area in epigenetics [22]. Plants contain several histone variants 
and enzymes that posttranslationally modify histones and influence gene regula-
tion. Application of chromatin immunoprecipitation followed by deep sequencing 
has given insight into the genome-wide distribution of histone variants and histones 
bearing different posttranslational modifications [22, 23]. Histone proteins are 
wrapped around DNA and forms a highly compact structure called nucleosome. 
Nucleosomes are composed of histone octamers that comprise two copies each of 
H2A, H2B, H3, and H4. A total of 147 base pair of DNA sequence is wrapped around 
the histone core. The N termini of histone proteins called N terminal tails undergo 
various chemical modifications like methylation or acetylation. Such histone modi-
fications are associated with either gene repression or gene activation [24, 25].  
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In plants methylation and deacetylation of H3K9 and H3K27 results into gene 
repression whereas acetylation and methylation of H3K4 and H3K36 is associated 
with gene activation and thus induces gene expression [26]. These covalent modifi-
cations in response to various environmental stresses regulates the transcription of 
wrapped DNA sequence by altering the packaging structure which either activates 
the DNA for the transcription or makes the structure more condensed so that 
transcription machinery is unable to reach it.
2.2.1 Histone acetylation/deacetylation
Addition of acetyl group to the N terminal Lysine of histones results into 
transcriptional activation of a DNA sequence [27]. Acetylation of N terminal lysine 
causes reduction in the net positive charge of histone and as a result the electrostatic 
force of attraction between the negatively charged DNA and positively charged 
histone reduces which leads to the loosening of chromatin and transcriptional acti-
vation of DNA [28]. The addition of acetyl group to Lysine is catalyzed by histone 
acetyltransferases (HATs). Five types of HATs have been identified in eukaryotes 
viz. GNAT—GCN5-related N-terminal acetyltransferase; MYST—MOZ, Ybf2/Sas3, 
Sas2, and Tip60; CBP—CREB binding protein; TFII250—TATA binding protein-
associated factors and the nuclear hormone-related HATs family. Only specific 
lysines in a histone protein are acetylated. In different histone proteins different 
lysine residues undergo modifications for instance, lysine residues of H4 (K5, K8, 
K12, K16, and K20) and histone H3 (K9, K14, K18, K23, and K27) are subjected to 
acetylation modifications [29, 30].
2.2.2 Histone methylation
Arginine and Lysine amino acids in histone proteins undergo methylation. 
Different arginine and lysine residues in different histones undergo different types 
of methylation (R3 of H2A, R3, K20 of H4 and K4, K9, K27, K36, R2, and R17 of 
H3 etc.) and these residues can be mono, di or tri methylated. Usually, arginine 
undergoes mono- and dimethylation only while lysine can undergo mono, di and 
tri methylation. Methylation can either activate or deactivate a gene depending 
on the nature of residues methylated for example H3K4 trimethylation activates 
transcription on the other hand K9 and K27 dimethylation in H3 acts as a repres-
sor [31]. Methylation affects the hydrophobicity of the histone and hence may 
change histone DNA interactions or may create binding site for various proteins 
which restricts the binding of transcription machinery and prevents transcription. 
Histone lysine methyltransferases (HKMT) and protein arginine methyltransferases 
(PRMT) catalyze methylation of lysine and arginine residues respectively [32].
2.3 miRNA directed DNA methylation
RNA directed DNA methylation (RdDM) is de novo cytosine methylation pri-
marily within the region of RNA-DNA sequence identity. Although RdDM pathway 
can methylate all sequence contexts, but it specifically methylates CHH sequences. 
The reason for this is that symmetrical methylation is maintained by maintenance 
methylation each time the DNA is replicated whereas the CHH methylation at many 
silenced loci is dependent on RNA-guided de novo methylation [33].
The 24-nt siRNAs are generated by DNA dependent RNA polymerase Pol IV 
enzyme, in association with RNA-dependent RNA polymerase 2 (RDR2), and 
processed by dicer-like 3 (DCL3) [34]. One strand of the resulting 24-nt dsRNA 
fragments is loaded onto argonaute 4 (AGO4) leading to generation of a silencing 
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effector complex. DNA methylation at sites having sequence homology to the 
siRNA is dependent on, Pol V, which is a DNA dependent RNA polymerase that 
transcribes non-coding RNAs. Transcription of Pol V is facilitated by a chromatin 
remodeling protein which is defective in RNA-directed DNA methylation 1 (DRD1)
[35]. KOW domain transcription factor1 (KTF1) which is an adaptor protein, medi-
ates binding of AGO4 and AGO4-bound siRNAs onto the transcripts generated by 
Pol V forming a silencing effector. This effector acts as signal for DRM2 to introduce 
methylation at target sites [35]. Development of stress tolerant crop has successfully 
been achieved by the use of RNAi technology. Transgenic rice plants with tolerance 
to drought were developed by silencing of activated C-kinase1 receptor [36].
3. Epigenetic changes in crops against abiotic stresses
Due to the unpredictable climate change, crop plants are frequently exposed to 
a variety of abiotic stresses resulting in reduced crop productivity. Analysis of the 
stress-associated genes and their regulation in response to the stress can be utilized 
to enhance understanding of the plant’s ability to adapt under changing climatic 
conditions. DNA methylation and/or histone modifications are influenced by 
abiotic/biotic factors resulting in the better adaptability of the plants to the adverse 
environmental conditions. Such epigenetic modifications provide a mechanistic basis 
for stress memory, which enables plants to respond more effectively and efficiently 
to the recurring stress as well as to prepare the offspring for potential future assaults.
3.1 Salt-induced epigenetic changes in crop plants
Environmental stresses result in hyper or hypomethylation of DNA. Evidence 
implicates epigenetic mechanisms in modulating gene expression in plants under 
abiotic stress. Promoter and gene-body methylation plays important role in regulat-
ing gene expression in genotype and organ specific manner under salt stress condi-
tions. Song et al. [37] observed that DNA methylation and histone modifications 
may have a combined effect on stress inducible gene as salinity stress was reported 
to affect the expression of various transcription factors in soybean. Ferreira et al., 
[38] emphasized that hypomethylation in response to salt stress may be correlated 
with altered expression of DNA demethylases. In another report [39] contrasting 
differences in cytosine methylation patterns were observed in salinity tolerant 
wheat cultivar SR3 and its progenitor upon salinity stress imposition. The responses 
of contrasting wheat genotypes under salt stress could be attributed to the altered 
expression levels of high affinity potassium transporters (HKTs) regulated through 
genetic and/or epigenetic mechanisms [40]. It was found that the coding region of 
high affinity potassium transporters (HKTs) showed variations in 5-mC content 
in the contrasting wheat genotypes. Salt stress significantly increased methylation 
level in wheat genotypes. Cytosine residues in CG context were all methylated, 
whereas increase in 5-mC was observed in CHG and CHH contexts in the shoot of 
a salt-sensitive wheat genotype under the stress. Variations in chromatin structure 
(facilitated through histone modifications) also play important role in salt toler-
ance. Kaldis et al. [41] reported that in Arabidopsis thaliana the transcriptional 
adaptor ADA2b (a modulator of histone acetyltransferases activity) is responsible 
for its hypersensitivity to salt stress. However, histone modifications are reversible 
and cross-talk between histone acetylation and cytosine methylation makes the 
plant responses more complex. Thus, salt stress affects genome-wide DNA methyla-
tion as well as histone modifications and these processes are linked to each other for 
synchronized action against salt stress [42].
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a salt-sensitive wheat genotype under the stress. Variations in chromatin structure 
(facilitated through histone modifications) also play important role in salt toler-
ance. Kaldis et al. [41] reported that in Arabidopsis thaliana the transcriptional 
adaptor ADA2b (a modulator of histone acetyltransferases activity) is responsible 
for its hypersensitivity to salt stress. However, histone modifications are reversible 
and cross-talk between histone acetylation and cytosine methylation makes the 
plant responses more complex. Thus, salt stress affects genome-wide DNA methyla-
tion as well as histone modifications and these processes are linked to each other for 
synchronized action against salt stress [42].
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3.2 Heat induced epigenetic changes in crop plants
Naydenov, [43] reported that upregulated epigenetic modulators like DRM2, 
nuclear RNA polymerase D1 (NRPD1) and NRPE1 may be responsible for increased 
genome methylation in Arabidopsis thaliana under heat stress conditions. Heat 
stress related study in rice showed reduction in seed size which is controlled by 
OsFIE1 (fertilization independent endosperm). Folsom and coworkers [44] in 
their study reported that DNA methylation and histone (H3K9me2) methylation 
are the two major factors governing the expression of OsFIE1. It was found that 
under heat stress both DNA methylation as well as histone methylation showed a 
decline (DNA methylation declined by 8.8% and 6.6% with respect to CH and CHG 
context). Reduced methylation levels resulted into lower expression of OsFIE1 
and lead to reduction in rice seed size. Histone modifications like acetylation have 
also been reported to occur under heat stress conditions. At high temperatures, a 
histone variant H2A.Z causes transcriptional changes in stress responsive genes 
[45]. Mutations in a gene GCN5 that codes for histone acetyltransferase, resulted in 
impaired transcriptional activation of heat stress responsive genes like HSAF3 and 
MBF1c and lead to thermal susceptibility of Arabidopsis thaliana [46]. The duration 
of heat treatment also has diverse effects on the epigenetic mechanisms emphasiz-
ing complexity in the epigenetic regulation of heat stress [47].
3.3 Epigenetic modifications in response to drought
Drought stress conditions generally tend to increase demethylation. It is also 
observed that DNA methylation shows tissue specificity. In Oryza sativa drought 
induced a total of 12.1% methylation differences accounted across different tissues, 
genotype and developmental stages. The overall DNA methylation level at the same 
developmental stage was lesser in roots than in leaves indicating significant role of 
roots under water insufficiency [48]. Correlation between DNA methylation and 
drought stress tolerance has been shown in lowland and drought-tolerant rice cultivars. 
IR20, a drought susceptible variety, undergoes hypomethylation under drought condi-
tions whereas the tolerant varieties “PMK3” and “Paiyur” showed hypermethylation. 
These changes in methylation pattern contributed to differential expression of stress 
responsive genes [49]. In another study conducted in rice it was illustrated that hypo-
methylation has significant role in the drought tolerant attribute of rice genotypes [50].
In several studies the abundance in transcript levels of drought responsive gene 
was correlated with changes in histone modification. Under drought conditions 
several histone alterations like acetylation, methylation, phosphorylation and 
sumoylation occurs [51]. Reports have documented that drought stress response is 
memorized through histone modification of various drought stress induced genes 
[52]. In a study in A. thaliana it was shown that an increase in H3K4 trimethylation 
and H3K9 acetylation on the promoter region and H3K23 and H3K27 acetylation 
on the coding regions is responsible for drought-induced expression of stress-
responsive genes [53]. Under stress conditions, accumulation of transcripts of stress 
responsive genes was positively correlated with histone modifications H3K9ac and 
H3K4me3 as both are marks of an active state of gene expression [54].
3.4 Epigenetic modifications in response to cold
Upon imposition of cold stress HDACs are upregulated that results into deacety-
lation of H3 and H4 and successively heterochromatic tandem repeats get activated 
[55, 56]. This results into reduction of DNA methylation and histone (H3K9me2) 
methylation at the targeted region of maize genome [39, 57]. In a study conducted 
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on the effect of cold on maize seedlings it was found that cold stress induced 
genome wide DNA methylation in root tissues except only in a 1.8-kb segment 
designated as ZmMI1. Under normal conditions ZmMI1 segment is methylated but 
under chilling conditions it is demethylated. This segment is representative of a 
stress responsive gene that plays role under stress conditions [58].
Even after 7 days of recovery, cold induced hypomethylation was not reverted 
back. In a similar study conducted by Saraswat et al. of DNA methylation pattern 
in cold grown maize 28 differentially amplified fragments were obtained. In silico 
analysis of these fragments revealed their role in several processes like photo-
synthesis, hormone regulation and in cold response [59]. A recent study in apple 
highlighted the importance of epigenetic changes in response to dormancy caused 
by low temperature. High chilling conditions decreased total methylation that lead 
to reinitiation of active growth and subsequent fruit set in apple [60, 61].
4. Techniques for deciphering epigenetic changes in plants
4.1 Histone modifications
4.1.1 Chromatin immunoprecipitation (ChiP) techniques
This technique is used to assay DNA–protein binding under in vivo conditions. 
This involves shearing genomic DNA into smaller fragments through sonication to 
generate fragments ranging 200–800 base pairs. Gentle formaldehyde treatment is 
given to crosslink proteins with DNA. Antibodies raised specifically for protein of 
interest are used to precipitate the protein-DNA complex. Precipitated DNA thus 
obtained is released by acid treatment and amplified by PCR [62].
4.1.2 ChiP-Seq
Advancements in the field of next-generation sequencing have made it possible 
to combines ChiP with next-generation sequencing technology such as Solexa. 
ChiP-Seq combines Chromatin immunoprecipitation and sequencing technologies 
to decipher genome wide distribution of histone proteins [62].
4.1.3 ChiP PCR
Immunoprecipitated DNA is amplified and quantified by real time PCR 
(RT-PCR) using TaqMan or Syber Green Technologies with specified primers for 
analysis of specific genomic regions associated with particular histones.
4.2 DNA methylation profiling in plants
Earlier studies focused on determining methylation status of the gene of inter-
est. With the use of microarray hybridization technology DNA methylation has 
been scaled up to genome wide level. Next generation sequencing platforms are now 
being used for the construction of genomic maps of DNA methylation at single-base 
resolution.
4.2.1 Genome-wide bisulfite sequencing
Bisulfite treatment converts unmethylated cytosines to uracil, allowing for the 
identification of methylated cytosines by comparing a treated sample to a reference 
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4.2.1 Genome-wide bisulfite sequencing
Bisulfite treatment converts unmethylated cytosines to uracil, allowing for the 
identification of methylated cytosines by comparing a treated sample to a reference 
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sample [63]. Bisulfite sequencing evaluates individual cytosines in a target sequence 
for essentially all cytosines in a genome (i.e. whole-genome bisulfate sequencing or 
WGBS).
4.2.2 Methylated DNA immunoprecipitation (MeDIP)
Genomic DNA is fragmented and precipitated with 5-methylcytosine-specific 
antibody. The precipitated DNA is then analyzed by PCR or whole genome tiling 
microarrays [64, 65].
4.2.3 Reduced-representation bisulfite sequencing (RRBS)
RRBS came into existence for the purpose of deciphering the mammalian meth-
ylome at low cost [66]. Bisulfite sequencing can be used for genomic fragments that 
are isolated with restriction enzymes thus providing single-nucleotide resolution 
of DNA methylation within each of the fragments. Availability of both sequence 
and methylation variation from same set of locus allows comparison of genetic and 
epigenetic differences. It is based on MspI restriction digestion and selection of (40 
and 220 basepair) digested fragments for bisulfite conversion and sequencing [67]. 
RRBS has been adopted for plant population studies and can be applied to species 
for which no reference genomes are available [68, 69]. RRBS has also been used in 
oak populations [70] and Brassica rapa [71].
4.2.4 Shotgun bisulfite sequencing
This combines bisulfite treatment of genomic DNA with next generation 
sequencing technology such as Solexa sequencing. The converted sequences 
are mapped to the reference genome sequence to identify methyl-cytosines 
[63, 72].
5. Conclusions
In view of the increasing stress conditions experienced by plants due to global 
climatic changes, epigenetics is considered as an important regulatory mecha-
nism that is influenced by environmental stimulus. This regulatory mechanism 
is of utmost significant importance in terms of its inheritance over generations. 
Advancements in the ultra-high-throughput techniques have revolutionized 
identification of epigenetic changes and improved our knowledge on effect of 
epigenetic changes on regulation of gene expression. Manipulation of DNA (de) 
methylation level at specific loci may allow us to regulate gene expression and 
the neighboring chromatin states, impacting cell physiology and biochemistry. 
Therefore, one of the possible, yet unexplored, ways to improve stress toler-
ance in crop plants may be to augment stress memory of the plants by targeted 
modification of the epigenome. Thus utilizing epigenetic variation for developing 
improved abiotic stress tolerant crop verities is an undertaking of paramount 
importance.
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Abstract
In the last decades, there has been a remarkable advance in the treatment of 
most types of cancer, improving the patient’s prognosis. During cancer progression, 
tumor cells develop several biological changes to support initiation, proliferation, 
and resistance to death. Nearly 50–80% of all oncologic patients experience rapid 
weight loss that is related to ~20% of cancer-related deaths. Cancer cachexia is a 
syndrome characterized by loss of skeletal muscle mass, anorexia, and anemia. 
A lot of effort in scientific investigation has contributed to the understanding of 
cancer processes, in which epigenetic changes, as microRNAs, can influence cancer 
progression. Therefore, useful strategies to control the cancer-induced epigenetic 
changes in the tumor cells can have a key role in a clinical perspective to decrease 
the cancer development and aggressiveness. Physical activity has been proposed 
as a suitable tool to manage tumor growth and cachexia and to improve the del-
eterious sequelae experienced during cancer treatment. Although the molecular 
mechanisms involved in these responses are poorly understood, this chapter aims 
to discuss the role of microRNAs in the cancer-induced epigenetic changes and how 
physical activity could influence the epigenetic control of tumor cells and cachexia 
and their potential role in clinical applications for cancer.
Keywords: epigenetic, cancer, hallmarks of cancer, cachexia, physical activity,  
tumor progression, microRNAs
1. Introduction: hallmarks of cancer, genetics and epigenetics
In the last decades, there has been a remarkable advance in the treatment of most 
types of cancer, improving the patient’s prognosis [1]. However, cancer remains 
the second major cause of death in the world and major cause of death in the rich 
countries [2, 3]. Cancer consists in a set of diseases characterized by the progres-
sive accumulation of mutations in the cell. These mutations provide changes in 
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1. Introduction: hallmarks of cancer, genetics and epigenetics
In the last decades, there has been a remarkable advance in the treatment of most 
types of cancer, improving the patient’s prognosis [1]. However, cancer remains 
the second major cause of death in the world and major cause of death in the rich 
countries [2, 3]. Cancer consists in a set of diseases characterized by the progres-
sive accumulation of mutations in the cell. These mutations provide changes in 
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the intracellular environment that induce advantages for its proliferation as well as 
greater resistance to mechanisms of cell death. A dysfunctional cluster of these cells 
is classically known as tumor. Currently, cancer is understood as a microenviron-
ment, in which the interactions between the cellular elements that compose it are 
determinants for the progression of the disease. For example, such elements would 
be involved in the interaction of tumor cells with normal cells such as fibroblasts, 
adipocytes, immune system cells, and endothelial cells [4–6]. All these cellular 
interactions support the development of cancer cachexia, which affects approxi-
mately 50–80% of cancer patients, and more than 25% of cancer deaths are a direct 
consequence of cachexia [7]. Cancer cachexia is directly related to a reduction in 
tolerance to physical effort [8], a reduction in tolerance to cancer treatments [9], 
and a shorter patient survival [10].
During cancer progression, tumor cells develop a number of important biologi-
cal changes to support initiation, proliferation, and resistance to death known 
as cancer hallmarks [5, 6]. Hanahan and Weinberg [5, 6] discuss 10 biological 
capabilities acquired by tumor cells that may be common among the different 
neoplasms and are important for the development and growth of the tumor mass, 
namely: (1) sustaining proliferative signaling, (2) loss of growth suppressors, (3) 
resisting cell death, (4) enabling replicative immortality, (5) inducing angiogenesis, 
(6) activating invasion and metastasis, (7) genome instability, (8) inflammation, 
(9) reprogramming of energy metabolism, and (10) loss of immune destruction 
[5, 6]. Among the 10 cancer-related biological processes, we point out that 6 are of 
fundamental importance for tumor mass growth.
1. Sustaining proliferative signaling
In normal tissues, there is a careful control of the release of growth and 
proliferation factors for the regulation of the cell cycle, which ensures adequate 
tissue architecture and function. However, tumor cells show abnormal prolif-
eration signaling, which promote exacerbated cell proliferation that generates 
morphological and functional tissue disarrangement. Some mutations are 
shown as probable causes of a normal cell to initiate a sustained prolifera-
tion and tumorigenesis. For example, mutation of PIK3CA gene and tyrosine 
kinases are mutations well described that promote sustained proliferation of a 
tumor cell [11].
2. Loss of growth suppressors.
Tumor cells bypass growth suppressor signals through the escape of mecha-
nisms that negatively control cell proliferation. Usually, tumor cells show loss 
of p53, a well-known tumor suppressor that controls proliferation, senescence, 
and cellular apoptotic programs, culminating in the uncontrolled growth of 
tumor cells. Tumor cells must also bypass powerful programs that negatively 
regulate cell proliferation; many of these programs depend on the actions of 
tumor suppressor genes [12].
3. Resisting cell death.
Over the past few decades, the literature has shown that apoptosis-
programmed cell death serves as a natural barrier to the development of 
cancer. Apoptosis is triggered in response to various physiological stresses 
that tumor cells undergo during the course of tumorigenesis or as a result 
of antineoplastic therapies. However, tumor cells have the ability to resist 
apoptosis and subsequently progress to conditions of malignancy and 
resistance to therapy [5].
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4. Enabling replicative immortality.
In healthy tissues, most normal cells have growth and cell division capacity 
controlled, but tumor cells have unlimited replicative potential, which favors 
the development of tumors [5].
5. Inducing angiogenesis.
In any tissue, the presence of vessels allows both the uptake of nutrients and 
oxygen and the release of substances not useful for the cells. Moreover, angio-
genesis occurs temporarily in response to some stimulation such as healing and 
the female reproductive cycle, being a transient process. However, this process 
is sustained and dysfunctional, since new vessels that present less coverage of 
pericytes appear continuously, favoring tumor growth [5].
6. Activating invasion and metastasis.
Tissue invasion and metastasis are probably the most relevant features 
developed by tumor cells, since the major cause of cancer death is associated 
with the formation of metastatic tumors. Metastasis is the formation of a new 
tumor, originating from the primary tumor. This is a complex process in which 
primary tumor cells invade blood and lymphatic circulation, spreading and 
forming colonies at distant sites from the primary tumor [13].
To reach the circulation and invade distant tissues, tumor cells need to modify 
their configuration and undergo a process named epithelial-mesenchymal transition 
(EMT). Thus, tumor cells with epithelial characteristics deactivate the mechanisms of 
cell adhesion and acquire locomotor properties, becoming able to infiltrate the stroma 
and have access to blood and lymphatic vessels [14, 15]. Moreover, for the colonization 
of tumor cells in distant tissues, the preparation of the “premetastatic niche,” which 
corresponds to the preparation of the metastatic tissue target of the tumor cells, is 
fundamental. The process of formation of the premetastatic niche involves an intricate 
cellular signaling at the systemic and local level, involving tumor-secreted factors and 
tumor-shed extracellular vesicle interaction [16]. Additionally, although Hanahan 
and Weinberg [5, 6] demonstrate possible treatments against hallmarks of cancer, the 
individual response to various treatments is still unpredictable [17, 18], demonstrat-
ing the plasticity of tumor cells [19–23]. The understanding of premetastatic niche is a 
new paradigm for the initiation of metastasis that can enable the clinical body to fight 
metastasis, and would benefit greatly from understanding the pathological processes 
occurring before the development of macrometastases [24].
2. Epigenetics and cancer
Cancer is considered a typically genetic disease; however, epigenetic modifications 
play an important role in the development and progression of cancer [5, 6, 25–27].
The term “epigenetics” was originally described by Conrad Waddington to 
describe hereditary changes in a cell phenotype that were independent of changes in 
DNA sequence [28].
Epigenetic modifications reflect a complexity of factors that determine the 
condensation state of chromatin, which determines whether the DNA is accessible to 
proteins that control gene transcription. A relaxed or “open” chromatin state allows 
gene transcription, while a condensed or “closed” chromatin condition prevents gene 
transcription [25, 26, 28–31]. Epigenetic mechanisms currently believed to play a 
role in the development of cancer include: (1) DNA methylation of cytosine bases 
Epigenetics
22
the intracellular environment that induce advantages for its proliferation as well as 
greater resistance to mechanisms of cell death. A dysfunctional cluster of these cells 
is classically known as tumor. Currently, cancer is understood as a microenviron-
ment, in which the interactions between the cellular elements that compose it are 
determinants for the progression of the disease. For example, such elements would 
be involved in the interaction of tumor cells with normal cells such as fibroblasts, 
adipocytes, immune system cells, and endothelial cells [4–6]. All these cellular 
interactions support the development of cancer cachexia, which affects approxi-
mately 50–80% of cancer patients, and more than 25% of cancer deaths are a direct 
consequence of cachexia [7]. Cancer cachexia is directly related to a reduction in 
tolerance to physical effort [8], a reduction in tolerance to cancer treatments [9], 
and a shorter patient survival [10].
During cancer progression, tumor cells develop a number of important biologi-
cal changes to support initiation, proliferation, and resistance to death known 
as cancer hallmarks [5, 6]. Hanahan and Weinberg [5, 6] discuss 10 biological 
capabilities acquired by tumor cells that may be common among the different 
neoplasms and are important for the development and growth of the tumor mass, 
namely: (1) sustaining proliferative signaling, (2) loss of growth suppressors, (3) 
resisting cell death, (4) enabling replicative immortality, (5) inducing angiogenesis, 
(6) activating invasion and metastasis, (7) genome instability, (8) inflammation, 
(9) reprogramming of energy metabolism, and (10) loss of immune destruction 
[5, 6]. Among the 10 cancer-related biological processes, we point out that 6 are of 
fundamental importance for tumor mass growth.
1. Sustaining proliferative signaling
In normal tissues, there is a careful control of the release of growth and 
proliferation factors for the regulation of the cell cycle, which ensures adequate 
tissue architecture and function. However, tumor cells show abnormal prolif-
eration signaling, which promote exacerbated cell proliferation that generates 
morphological and functional tissue disarrangement. Some mutations are 
shown as probable causes of a normal cell to initiate a sustained prolifera-
tion and tumorigenesis. For example, mutation of PIK3CA gene and tyrosine 
kinases are mutations well described that promote sustained proliferation of a 
tumor cell [11].
2. Loss of growth suppressors.
Tumor cells bypass growth suppressor signals through the escape of mecha-
nisms that negatively control cell proliferation. Usually, tumor cells show loss 
of p53, a well-known tumor suppressor that controls proliferation, senescence, 
and cellular apoptotic programs, culminating in the uncontrolled growth of 
tumor cells. Tumor cells must also bypass powerful programs that negatively 
regulate cell proliferation; many of these programs depend on the actions of 
tumor suppressor genes [12].
3. Resisting cell death.
Over the past few decades, the literature has shown that apoptosis-
programmed cell death serves as a natural barrier to the development of 
cancer. Apoptosis is triggered in response to various physiological stresses 
that tumor cells undergo during the course of tumorigenesis or as a result 
of antineoplastic therapies. However, tumor cells have the ability to resist 
apoptosis and subsequently progress to conditions of malignancy and 
resistance to therapy [5].
23
A Landscape of Epigenetic Regulation by MicroRNAs to the Hallmarks of Cancer and Cachexia…
DOI: http://dx.doi.org/10.5772/intechopen.84847
4. Enabling replicative immortality.
In healthy tissues, most normal cells have growth and cell division capacity 
controlled, but tumor cells have unlimited replicative potential, which favors 
the development of tumors [5].
5. Inducing angiogenesis.
In any tissue, the presence of vessels allows both the uptake of nutrients and 
oxygen and the release of substances not useful for the cells. Moreover, angio-
genesis occurs temporarily in response to some stimulation such as healing and 
the female reproductive cycle, being a transient process. However, this process 
is sustained and dysfunctional, since new vessels that present less coverage of 
pericytes appear continuously, favoring tumor growth [5].
6. Activating invasion and metastasis.
Tissue invasion and metastasis are probably the most relevant features 
developed by tumor cells, since the major cause of cancer death is associated 
with the formation of metastatic tumors. Metastasis is the formation of a new 
tumor, originating from the primary tumor. This is a complex process in which 
primary tumor cells invade blood and lymphatic circulation, spreading and 
forming colonies at distant sites from the primary tumor [13].
To reach the circulation and invade distant tissues, tumor cells need to modify 
their configuration and undergo a process named epithelial-mesenchymal transition 
(EMT). Thus, tumor cells with epithelial characteristics deactivate the mechanisms of 
cell adhesion and acquire locomotor properties, becoming able to infiltrate the stroma 
and have access to blood and lymphatic vessels [14, 15]. Moreover, for the colonization 
of tumor cells in distant tissues, the preparation of the “premetastatic niche,” which 
corresponds to the preparation of the metastatic tissue target of the tumor cells, is 
fundamental. The process of formation of the premetastatic niche involves an intricate 
cellular signaling at the systemic and local level, involving tumor-secreted factors and 
tumor-shed extracellular vesicle interaction [16]. Additionally, although Hanahan 
and Weinberg [5, 6] demonstrate possible treatments against hallmarks of cancer, the 
individual response to various treatments is still unpredictable [17, 18], demonstrat-
ing the plasticity of tumor cells [19–23]. The understanding of premetastatic niche is a 
new paradigm for the initiation of metastasis that can enable the clinical body to fight 
metastasis, and would benefit greatly from understanding the pathological processes 
occurring before the development of macrometastases [24].
2. Epigenetics and cancer
Cancer is considered a typically genetic disease; however, epigenetic modifications 
play an important role in the development and progression of cancer [5, 6, 25–27].
The term “epigenetics” was originally described by Conrad Waddington to 
describe hereditary changes in a cell phenotype that were independent of changes in 
DNA sequence [28].
Epigenetic modifications reflect a complexity of factors that determine the 
condensation state of chromatin, which determines whether the DNA is accessible to 
proteins that control gene transcription. A relaxed or “open” chromatin state allows 
gene transcription, while a condensed or “closed” chromatin condition prevents gene 
transcription [25, 26, 28–31]. Epigenetic mechanisms currently believed to play a 
role in the development of cancer include: (1) DNA methylation of cytosine bases 
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in CG-rich sequences, called CpG islands; (2) posttranslational modification of his-
tones (proteins that form the nucleosomes), which regulate the packaging structure 
of DNA (called chromatin); and (3) microRNAs (miRs) and noncoding RNAs [25, 
26, 28–31].
Although DNA methylation and histone modifications are important com-
ponents of epigenetic regulation [25, 26, 28–31], here we will focus on the role of 
alterations in miRs expression, since their expression is regulated through various 
mechanisms, including epigenetic modifications, and because their functions are 
aberrant in cancer, boosting the progression of the disease.
3. MicroRNAs
MiRs are a class of molecules that have an important role in the regulation of 
protein expression, even after the transcription of messenger RNA (mRNA).
MiRs are characterized as small RNAs of approximately 17–22 nucleotides, 
noncoding proteins, that act by binding to the mRNA, repressing the translation of 
proteins. MiRs are found in several organisms as animals and plants and control a 
lot of physiological and pathological processes. Evidence shows that at least one-
third of all biological processes are controlled by miRs [32].
This class of molecules was first observed in 1993 by Lee et al., which demon-
strated that miR lin-4 was associated with larval development of C elegans [33]. 
Although the discovery of the first miR occurred in 1993, miRs researches only pro-
gressed in the year 2000, when miR lin-4 was found to participate in the posttran-
scriptional control of lin-14 protein through the complementary binding of miR 
with the 3’ untranslated region (3’UTR region) of the protein mRNA [34]. After the 
pioneering study by Hong et al., many studies have been developed to demonstrate 
that small RNAs could participate in posttranscriptional controls. Thus, Ambros 
observed that miR let-7 had a partially complementary binding to the 3’UTR region 
of the lin-4 protein mRNA, negatively controlling its protein expression [34, 35]. 
These findings led to the discovery of new miRs, and more than 30,000 mature 
miRs are now known in the most diverse organisms [32].
As mentioned, miRs exert their action through partially or totally binding to 
the 3’UTR region of the target mRNA. The complete complementarity induces 
the degradation of the mRNAs, being commonly observed in plants. In mam-
mals, there is partial complementarity, which inhibits the translation of the target 
transcript [36].
The miRs bind their seed region, that in mammals comprises 2–8 nucleotide, 
with the target mRNA, present in the 3’UTR region, where only some of the base 
pairs are complementary. Due to the imperfect pairing and small size of these 
molecules, there is the possibility of an miR presenting various targets [36].
The biogenesis of miRs begins with the action of the enzyme RNA polymerase 
II that generates a primary transcript called pri-miR. The pri-miR has a hairpin 
double helix structure with approximately 300 nucleotides. Still in the cell nucleus, 
the Drosha enzyme and its cofactor DGCR8 cleave the pri-miR, forming its 
precursor, the pre-miR. The pre-miR is exported to the cytosol by the exportin 5 
enzyme. In the cytoplasm, the pre-miR is cleaved by the enzyme dicer, originating 
two strands together, one being the mature miR and the other called an antisense. 
Dicer cleaves again and separates the duplex. The mature miR is then incorporated 
by a multimeric complex named RISC that contains argonaute protein (AGO) as 
showed in Figure 1, while the other strand can be degraded or incorporated in 
other RISC complex to exert negative regulation of target mRNAs [32].
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Recently, the interest in the study of miRs has increased, since they exert a 
paracrine function and are effective in the tissue communication. Also, an miR can 
exert the same function on different cell types, as different function in the same 
cells. In 2008, the presence of miRs in plasma and other biological fluids was dis-
covered, demonstrating that miRs are viable in the extracellular environment and 
important signaling molecules. There are circulating miRs in almost all biological 
fluids, including: milk, plasma, serum, saliva, urine, tear, and amniotic fluid [37]. 
Circulating miRs are remarkably stable, resis tant to RNase activity, freeze-thaw 
cycles as well as extreme pH. This stability is associated with the carriers that carry 
them and can be secreted by the cells through different vesicles such as exosomes, 
HDL, or AGO proteins containing apoptotic bodies [37].
Figure 1. 
Canonical pathway of biogenesis of miRs [31]. https://smart.servier.com/image-set-download/.
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4. microRNAs and cancer
The miRs play a key role in the control of various physiological and pathological 
processes. Many studies demonstrate the participation of miRs during the progres-
sion of several types of cancer. MiRs present altered expression in tumors, and 
many studies are being conducted with this new class of molecules to elucidate their 
role in controlling the pathophysiology of the disease [36, 38, 39].
There is evidence that miRs are also involved in regulation of hallmarks of cancer 
and thus in the progression of cancer [5, 15]. In view of this, there is an effort by the 
scientific community to understand the mechanisms involving miRs and the devel-
opment of cancer aiming to develop cancer-specific gene therapies [40]. The aim of 
these efforts is to improve responses to conventional drugs for the cancer treatment, 
specifically suppress oncogenic processes, and improve the prognosis of the disease.
The miR-124 was one of the first studied miRs involved in the pathogenesis 
of cancer [41]. MiR-124 was silenced in more than 10 types of cancer, as breast, 
colorectal, liver, and lung cancer. This silencing promotes increased expression 
of CDK6, which affects the phosphorylation state of Rb protein, favoring tumor 
progression [42]. Other miRs silenced are miR-9-1 and miR-9-3. When analyzing 
the expression of miR-9-3 in primary and metastatic tumors, it was observed that 
metastatic tumors have a lower expression of miR-9-3. Also, patients with lower 
miR-9-3 expression in the tumor have a lower survival rate than patients with 
higher expression of miR-9-3 [43].
Garzon et al. [40] observed that there is a decrease in miRs-15a/16 expression 
in patients with chronic lymphoid leukemia and in chronic lymphocytic leukemia 
tumor cells CLL23. Thus, the authors ectopically increased the expression of 
miRs-15a/16 in CLL23 tumor cells and investigated the processes of proliferation 
and apoptosis. It was observed that with the increase of miRs-15a/16 expression in 
CLL23 tumor cells, there is a higher apoptosis and less cellular proliferation. This 
response occurs because miRs-15a/16 target BCL-2 protein, an important antiapop-
totic factor. BCL-2 is known to be increased in tumors of cancer patients [40].
Moreover, miR-34 has been shown to be downregulated in pancreatic cancer. 
The overexpression of miR-34 in these cells increases apoptosis and inhibition of 
autophagy, reducing tumor growth [44]. Another example is the miR Let-7 family, 
which targets HRAS and HMGA2 as well as participates in the regulation of prolif-
eration and cell cycle. Let-7 family members are also negatively regulated in various 
types of cancers, and their overexpression results in inhibition of tumor growth in 
different cancer models [45, 46]. This is due to the fact that Let-7 targets the major 
components of cell cycle progression, such as KRAS, CCDN1, CDC34, HMGA2, 
E2F2, and Lin28 [45, 46].
In contrast, miRs may also be increased in cancer and their biological effects 
may potentiate the development of the disease. For example, the case of miR-21 has 
a high expression in tumors of glioblastoma, pancreatic cancer, breast cancer, and 
colon cancer. Inhibition of miR-21 in glioblastoma cells was able to increase caspase 
activity and promote apoptosis of tumor cells. One possible explanation is that 
miR-21 targets PTEN protein and PDCD4 protein, functioning as an antiapoptotic 
agent in cancer [47].
MiRs are also involved in several other cancer factors, such as in the formation of 
metastases. Zhou et al. [48] observed that miR-105 is involved with preparation of 
the “premetastatic niche.” The authors demonstrated that animals with breast cancer 
exhibit high levels of miR-105 expression in both tumor and circulation and that ele-
vated miR-105 levels in the circulation promote the destruction of endothelial barriers 
and increase vascular permeability in the target metastatic organ. Inhibition of miR-
105 in tumor cells from highly metastatic breast cancer prevented the development of 
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metastasis [48]. Another miR associated with metastasis formation is the family of 
miR-200. The 200 family plays a role in repress proteins that promote the epithelial-
mesenchymal transition. However, its expression is reduced in tumors in response 
to increased expression of the long noncoding RNA ATB that competes with the miRs 
binding site of the 200 family, reducing its expression and function, which favors the 
negative regulation of E-cadherin and increase of ZEB proteins expression [49]. The 
current involvement of miRs in the hallmarks of cancer is elucidated in Figure 2.
4.1 Physical activity as nonpharmacological therapy
Although in recent time cancer treatments have evolved considerably, there are 
still no responsive patients to the treatments, which suggest the need for strategies 
to reduce the incidence and aggressiveness of cancer. At same time, American Cancer 
Society recommends to cancer survivors the participation in 150 min of moderate 
intensity exercise per week. There is evidence that physical activity improves quality 
of life, treatment response, decreases cancer recurrence due physical fitness improve-
ment of patients, and survivors [50]. In the present moment, there is strong academic 
effort in clinical trials being performed, investigating about perspective and limita-
tion of inclusion physical activities in the cancer therapy. The main investigations 
focus in physiological aspects and appropriate modalities and methods [51–53].
Figure 2. 
Landscape of investigative field involving miRs, molecular basis, and the hallmarks of cancer. Currently, 
among the miRs related to the cancer hallmarks, only miR-21 and its target, the mRNA of PDCD4, PTEN, 
TPM1, HIF1α and VEGF was established the beneficial relationship with the effects of physical activity in the 
tumor (thin green arrows) [43–49, 83, 84]. https://smart.servier.com/image-set-download/.
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metastasis [48]. Another miR associated with metastasis formation is the family of 
miR-200. The 200 family plays a role in repress proteins that promote the epithelial-
mesenchymal transition. However, its expression is reduced in tumors in response 
to increased expression of the long noncoding RNA ATB that competes with the miRs 
binding site of the 200 family, reducing its expression and function, which favors the 
negative regulation of E-cadherin and increase of ZEB proteins expression [49]. The 
current involvement of miRs in the hallmarks of cancer is elucidated in Figure 2.
4.1 Physical activity as nonpharmacological therapy
Although in recent time cancer treatments have evolved considerably, there are 
still no responsive patients to the treatments, which suggest the need for strategies 
to reduce the incidence and aggressiveness of cancer. At same time, American Cancer 
Society recommends to cancer survivors the participation in 150 min of moderate 
intensity exercise per week. There is evidence that physical activity improves quality 
of life, treatment response, decreases cancer recurrence due physical fitness improve-
ment of patients, and survivors [50]. In the present moment, there is strong academic 
effort in clinical trials being performed, investigating about perspective and limita-
tion of inclusion physical activities in the cancer therapy. The main investigations 
focus in physiological aspects and appropriate modalities and methods [51–53].
Figure 2. 
Landscape of investigative field involving miRs, molecular basis, and the hallmarks of cancer. Currently, 
among the miRs related to the cancer hallmarks, only miR-21 and its target, the mRNA of PDCD4, PTEN, 
TPM1, HIF1α and VEGF was established the beneficial relationship with the effects of physical activity in the 
tumor (thin green arrows) [43–49, 83, 84]. https://smart.servier.com/image-set-download/.
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Physical fitness is the ability to perform daily tasks with vigor and alertness, 
without excessive fatigue and with energy to enjoy leisure activities and to meet 
unforeseen emergencies [54]. It is known that physical activity induces beneficial 
adaptations to the body, improving physical fitness [55]. Physical activity encom-
passes both physical exercise with controlled volume, intensity, and duration 
or recreational activities [56]. There is evidence that support the importance of 
maintaining a physically active life for health. Healthy individuals or cardiovascular 
patients who have low physical capacity tend to have a lower survival rate [57]. 
Corroborating with these clinical and epidemiological data, experimental results 
show that rats with high capacity to run present a higher survival (~45%) when 
compared to those that have low capacity to run [58, 59]. Regular physical activities 
are recognized as nonpharmacologic preventive approach and treatment for chronic 
diseases [60–62], including cancer [63–65]. Several studies also demonstrate 
that aerobic physical activity normalizes the expression of aberrant miRs due to 
diseases such as myocardial infarction, hypertension, diabetes, and obesity. That 
these pathologies induce molecular and structural alterations and aerobic physical 
exercise is a beneficial stimulus for the reversal and control of these deleterious 
alterations such as muscle mass decrease and microvascular rarefaction [66–69].
4.2 Physical activity, cancer, and microRNAs: new perspectives
There is evidence that aerobic physical activity reduces the incidence of several 
types of cancer [65]. Moore et al. [65] demonstrated that regular physical activity 
resulted in decreased incidence of 13 types of cancer in 26 analyzed in 1.44 mil-
lion adults. The individuals involved with higher daily volumes of physical activ-
ity presented decrease in the incidence in esophageal adenocarcinoma, myeloid 
leukemia, myeloma, liver, lung, kidney, gastric, endometrial, colon, head and neck, 
rectal, bladder, and breast cancer. The effects of physical activity on reducing the 
incidence of cancer were independent of other factors such as body mass index 
(BMI), smoking, geographical region, use of hormonal therapy, and ethnicity [65]. 
Cancer patients with reduced physical capacity have a worse prognosis [70–72]. 
Colon cancer patients have a reduction of more than 20% in maximal oxygen 
consumption (VO2 máx.) compared to their healthy peers [71]. Patients with lung 
cancer and colon cancer with greater physical capacity present a higher survival 
compared to patients with lower physical capacity [73]. Aerobic physical activity 
attenuates tumor growth in different animal models [74–78]. However, the molecu-
lar mechanisms involved in this response are poorly understood. Recently, Pedersen 
et al. [79] showed that 4 weeks of prior voluntary physical activity was able to delay 
tumor initiation and attenuate tumor growth in various cancer models in mice and 
was also efficient in decreasing the formation of metastatic nodules. The authors 
demonstrated that physical activity increases the mobilization and redistribution 
of NK cells to the tumor microenvironment due to the systemic increase of IL-6 
and epinephrine induced by physical activity. This increase of immune response 
in the tumor microenvironment was proposed as the main mechanism induced by 
aerobic physical activity for the attenuation of tumor growth [79]. Betof et al. [77] 
also demonstrated that previous aerobic physical activity is capable of attenuat-
ing tumor growth in the 4T1 breast cancer model. The authors demonstrated that 
aerobic physical activity increased the pericytic coverage of tumor vessels and 
apoptosis of tumor cells, provided a greater functional neo-vascularization on the 
tumor endothelium, and consequently reduced the hypoxia regions in the tumor 
microenvironment [77]. Pigna et al. demonstrated that aerobic physical activity is 
also efficient in increasing the survival of animals injected with C26 (colon cancer) 
tumor cells lineages [80].
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However, it is important to note that only two of the studies that observed 
attenuation of tumor growth induced by aerobic physical activity investigated the 
role of miR in this response, both in mice breast cancer injected with MC4-L2. 
Khori et al. observed that aerobic physical activity was efficient in reducing miR-
21 gene expression in animal tumors, inhibiting proliferation and migration of 
tumor cells. In addition, the miR-21 downregulation was associated with increase 
of gene and protein PDCD4 expression and TPM1, two tumor suppressor genes 
[81]. Isanejad et al. [82] also demonstrated that aerobic physical activity reduces 
tumor growth and increased the gene expression levels of miRs-206 and let-7 in 
the mammary tumor. Moreover, exercise-increased expression of miR-206 and 
let-7 decreased in the levels of gene expression of HIF-1α, CD31, and VEGF in 
mice, suggesting an anti-angiogenic effect, which contributed to the decrease of 
tumor angiogenesis and growth [82]. Both Khori et al. and Isanejad et al. observed 
involvement of miRs in the aerobic physical activity response, which enhanced the 
effects of treatment with tamoxifen and letrozole, respectively, on tumor growth 
and molecular responses [81, 82].
These results indicate the potential of physical activity in modulating the decom-
pensated miRs in the tumor. Also, we can point to the potential of physical activity 
to an improved miRs profile in the tumor, and their direct role in the reduction of 
the tumor growth and aggressiveness. However, currently there is a gap in elucidat-
ing about the global molecular mechanisms by which physical activity induces the 
phenotypical improvement. Therefore, the interaction between cancer, miRs and 
the effect of physical activity in the several cancer types is a promisor field of inves-
tigation that certainly will develop a lot of knowledge about preventive, therapeutic, 
as well as the mechanisms by which physical activity acts is cancer.
5. Cancer cachexia
Cancer cachexia (CC) is a multifactorial syndrome characterized by continuous 
loss of muscle mass that can be conjugated or not by loss of fat mass. CC cannot be 
completely reversed by conventional nutritional support and leads to progressive 
functional disability [83]. The pathophysiology of CC is characterized by a negative 
protein balance, anorexia, and metabolic abnormalities [84]. CC individuals usually 
present with muscle weakness, asthenia and poor response to anticancer treatment, 
all of these processes contributes to patient mortality [85, 86].
Muscle atrophy in CC results from the imbalance in protein turnover due to 
exacerbated proteolytic activation, reduction of protein synthesis pathways, and 
reduced regenerative capacity in skeletal muscle [87, 88].
In this context, it is essential to understand the role of epigenetic factors in the 
loss of muscle mass in CC. There is massive evidence that epigenetic factors, for 
example histone acetylation, DNA methylation and miRs orchestrate processes such 
as muscle proliferation and differentiation, as well as skeletal muscle regenerative 
capacity [89–92]. To elucidate about the epigenetic factors that lead to the loss of 
muscle mass in CC also may contribute to the emergence of new therapies for the 
prevention and treatment of the syndrome.
In this section, we will approach about the role of miRs in the regulation of 
muscular trophism. Skeletal muscle presents a set of miRs that are enriched in 
this tissue and mediate mechanisms of proliferation, differentiation, and protein 
synthesis. These miRs are known as myomiRs [32]. The most studied myomiRs are 
the -133a/b, −206, and −1 miRs. These miRs are known to display target genes such 
as IGF-1R, known hypertrophic pathway promoters [32] and PAX3 and PAX7, genes 
that regulates proliferation of satellite cells [93]. In another view, there are many 
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that regulates proliferation of satellite cells [93]. In another view, there are many 
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studies showing the role of several other miRs orchestrating prohypertrophic and 
procatabolic genes in the skeletal muscle [32, 94].
Interesting advances have been made in studies about the of role skeletal muscle 
enriched miRs in CC. Lee et al. [95] conducted a study in order to investigate the 
profile of miRs expressed in skeletal muscle of cachectic mice. The researchers 
performed a sequencing of the anterior tibial muscle of LLC tumor-bearing mice, 
animal model of orthotopic lung cancer, and compared them to healthy mice. The 
miRs-147-3p, −299a-3p, 1933-3p, 511-3p, 3473d, 233-3p, 431-5p, 665-3p, and 205-3p 
were found to be differently expressed. Genetic ontology analyzes of these miRs 
indicate a relationship with cellular survival pathways, inflammatory response, cell 
cycle, cell development, and cell morphology through crosstalk of several path-
ways, with target genes such as FOXO3, HRAS, P38, MAPK, MYC, and EIF4E. We 
can note that HRAS and MYC are also related to hallmarks of cancer [95].
Narasimhan et al. [96] conducted another study evaluating the profile of miRs 
in muscle tissue of CC patients. In this study, human rectal abdominal muscle 
samples were collected during the tumor resection surgery of colon and pancreatic 
cancer patients. Sequencing analyzes demonstrated that eight miRs were differen-
tially expressed between cachectic individuals and controls. The miRs let-7d-3p, 
3184-3p, and −1296-5p were selected and these miRs were increased in cachectic 
patients relative to controls. The authors performed in-silico analyzes and pointed 
out that these miRs targets genes related to adipogenesis, myogenesis (SULF1 and 
DLK1), inflammation, and immune response (RPS6KA6) [96].
The loss of fat mass is not present in all cases of CC; however, the role in energy 
metabolism of adipose tissue in CC is important. Therefore, studies are being 
conducted to understand the function of miRs in maintaining of adipose tissue in 
cachetic state. Kulyté et al. [97] conducted a sequencing analyzes of miRs in adipose 
tissue of cachectic and noncachectic gastrointestinal cancer patients, the authors 
found difference in expression of nine miRs between cachectic and noncachectic 
patients. MiR-378 was selected due to an increased expression in the adipose 
tissue of cachectic patients compared to noncachectic patients. The inhibition and 
overexpression of miR-378 on human adipose-derived stem cells were performed; 
overexpression of miR-378 decreased expression of the HSL, PLIN1, and ATGL 
protein and consequently increased lipids catabolism and release of glycerol [97].
MiRs are also present in body fluids such as saliva, tear, and blood. In this sense, 
studies are being conducted with the purpose of understanding the role of circulat-
ing miRs in CC. Okugawa et al. [98] showed that the expression of circulating miR-
21 increases in the patients with cachectic colon cancer; however, the expression of 
miR-21 is not different in the skeletal muscle in compared to noncachectic patients 
[98]. The circulating miRs can be studied as biomarkers for some pathological 
processes. Studies in humans and animals have looked for miRs that are biomarkers 
in order to early diagnose CC [94]; however, it should be noted that many of these 
miRs are not widely accepted as biomarkers by the medical and scientific commu-
nity and some are not even validated in humans [96].
The role of miR-21 in CC was also investigated by He et al. [99], which showed 
that miR-21-enriched exosomes were found in the circulation of pancreatic and lung 
cancer patients. Myoblast cells cultures treated with these miR-21-enriched exo-
somes showed an interaction of the microvesicle with the muscle cells that induced 
cell death via TLR8 protein, an endosomal receptor that recognizes single-stranded 
RNA (ssRNA), and can recognize ssRNA viruses such as Influenza, Sendai, and 
Coxsackie B viruses. TLR8 is a protein binding to RNA and is able to recruit MYD88 
and leads to activation of the transcription factor NF-κB and an antiviral response. 
TLR8 agonists have undergone clinical trials as immune stimulants in combination 
therapy for some cancers [99].
31
A Landscape of Epigenetic Regulation by MicroRNAs to the Hallmarks of Cancer and Cachexia…
DOI: http://dx.doi.org/10.5772/intechopen.84847
There are few studies showing a direct association of the action of miRs and 
their targets about processes involved in the progression or reversal of CC. The 
issue promises a great field for development of results that can be clinically relevant 
and useful in the future. Additionally, skeletal muscle is highly responsive to both 
physical activity and CC, and investigation of skeletal muscle-enriched miRs and 
the effect of physical activity and exercise in these miRs are promising to elucidate 
about CC. The next section will cover this topic.
5.1 Relationship between physical exercise and the mediators of cachexia
There is massive evidence that support the importance of maintaining aerobic 
fitness for health. Low aerobic fitness is an independent indicator of early death in 
individuals with cardiovascular and/or healthy individuals [57]. The physical train-
ing regulates the expression of miRs in a profile that enables endurance performance 
and physical fitness. Aerobic exercise prevents a number of chronic-degenerative 
diseases [60], including cancer [65]. Resistance training increases muscle mass and 
strength and contributes to increased functional capacity [87]. Therefore, aerobic 
and resistance training are presented as a therapeutic potential for CC patients and 
presents an interesting field of investigation to clarify clinically relevant process 
related to CC. However, due to clinical difficulties and poor safety conditions, there 
is a lack in human studies about the role of physical exercise in CC patients. In this 
context, the use of animal models in well-controlled studies has shown that physical 
training may be promising in the treatment of CC. Oh et al. demonstrated that the 
C26, orthotopic colon cancer cachectic mice, when submitted to resistance training 
and aerobic training protocols presented lower muscle mass loss [100]. Partial pres-
ervation of muscle mass due to physical training is associated with higher expression 
of proteins such as mTOR, IGF, and myogenin in the trained C26 mice when com-
pared to sedentary C26 mice [100]. Pigna et al. demonstrated that voluntary aerobic 
activity in C26 mice also improves the autophagy flow preventing skeletal muscle 
loss in association with autophagy regulatory drugs [80]. Baggish et al. showed for 
the first time that miRs-21, miR-146a, and -133a are candidates to be biomarkers of 
aerobic physical training in the circulation [101].
Skeletal muscle trophism is regulated by the action of some miRs, and exercise 
controls the expression of these miRs. As example, IGF-IR mRNA encodes IGF1 
receptor protein and is a target of miR-133. A study shows that IGF-IR overexpression 
results in increased PI3K-AKT-mTOR pathway that mediated muscle hypertrophy, 
in myocyte cell culture, and that knockdown of IGF-IR decreases the hypertrophic 
signal. MiR-133 decreases the expression of IGF-IR, and consequently decreases AKT 
and mTOR phosphorylation, regulating the development of skeletal muscle [102]. 
Furthermore, aerobic physical exercise decreases the expression of miR-133a [103].
In conclusion, many studies show that both aerobic and resistance physical exer-
cise control the expression of miRs that are dysregulated by diseases as hypertension, 
diabetes, and obesity [68, 69, 104, 105]. Physical exercise rebalances the expression of 
the miRs involved with those alterations reverses structural deleterious changes in the 
skeletal muscle and restores tissue or prevents deterioration [66]. However, there are 
no studies designing an miR profile from CC skeletal muscle and the prevention of 
muscle catabolism by physical exercise, which is interesting for future investigation.
6. Conclusions
The effects of physical activity as nonpharmacological adjuvant for cancer 
patients are effective to the disease and survivorship in cancer, since it improves 
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6. Conclusions
The effects of physical activity as nonpharmacological adjuvant for cancer 
patients are effective to the disease and survivorship in cancer, since it improves 
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quality of life and decreases the recurrence of cancer. Currently, there are massive 
efforts to include exercise in the therapeutic approach to patients. Furthermore, 
studies show several benefits of aerobic physical activity in reducing the risk of 
incidence of cancer. Physical activity also reduces expenditures for public health 
agencies, both by decrease of cancer incidence and can attenuate the side effects or 
resistance related to anticancer treatment. However, little is known about the epi-
genetic, molecular, and cellular mechanisms involved in this response, both related 
to hallmarks of cancer, to cachexia process, and the comprehension about physical 
training effect in oncologic patients remains incipient.
Recently, the attentions of several areas of the scientific community have turned 
to miRs, epigenetic regulators in different cellular processes, as in tumorigenesis. To 
date, studies postulating the effects of aerobic physical activity on the modulation 
of decompensated miRNAs in the tumor and its potential as cancer gene therapy in 
cancer are rare. Thus, the identification of miRs modified by cancer of sedentary 
animals in comparison with trained animals can lead to the identification of miRs 
with therapeutic potential and elucidate about epigenetic mechanisms involved in 
physical activity therapy. However, it is necessary to better understand these mecha-
nisms both in cell culture and in animal models of cancer in order to transpose into 
translational medicine in a whole approach. In this sense, extensive basic research is 
needed to elucidate these mechanisms in order to establish relationships about the 
role of miRs, the 10 biological capacities, the hallmarks of cancer, and if how these 
processes can be reversed by physical activity. Another interesting issue to be inves-
tigated is about the involvement of the miRs regulated by the physical activity in the 
CC and how these miRs are related to the 10 capacities and the hallmarks of cancer. 
These approaches can extensively clarify about cancer mechanisms and improve 
future physical activity therapy.
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Chapter 4
Consequences of Artificial Light 
at Night: The Linkage between 
Chasing Darkness Away and 
Epigenetic Modifications
Abraham Haim, Sinam Boynao and Abed Elsalam Zubidat
Abstract
Epigenetics is an important tool for understanding the relation between envi-
ronmental exposures and cellular functions, including metabolic and proliferative 
responses. At our research center, we have devolved a mouse model for characterizing 
the relation between exposure to artificial light at night (ALAN) and both global DNA 
methylation (GDM) and breast cancer. Generally, the model describes a close associa-
tion between ALAN and cancer responses. Cancer responses are eminent at all light 
spectra, with the prevalent manifestation at the shorter end of the visible spectrum. 
ALAN-induced pineal melatonin suppression is the principal candidate mechanism 
mediating the environmental exposure at the molecular level by eliciting aberrant 
GDM modifications. The carcinogenic potential of ALAN can be ameliorated in 
mice by exogenous melatonin treatment. In contrast to BALB/c mice, humans are 
diurnal species, and thus, it is of great interest to evaluate the ALAN-melatonin-GDM 
nexus also in a diurnal mouse model. The fat sand rat (Psammomys obesus) provides 
an appropriate model as its responses to photoperiod are comparable to humans. 
Interestingly, melatonin and thyroxin have opposite effects on GDM levels in P. obesus. 
Melatonin, GDM levels, and even thyroxin may be utilized as novel biomarkers for 
detection, staging, therapy, and prevention of breast cancer progression.
Keywords: melatonin, thyroxin, light-at-night, global DNA methylation, diurnal species, 
breast cancer, biomarkers
1. Introduction
Since the invention of electrical light in 1879 by Thomas Alva Edison, artificial 
light at night (ALAN) has become a definitive feature of human development with 
accelerated increase concurrent with urbanization and industrialization. The light 
emitted from the original bulb of Edison known as incandescent bulb was weak, 
with a dominant long wavelength emission above 560 nm. Most of the incandescent 
electrical energy is dissipated as heat energy, thus making this type of illumination 
energetically inefficient. Therefore, new illumination technologies were developed, in 
order to discover efficient bulbs that transfer most of the electrical energy into light. 
White fluorescent and light-emitting diodes (LED) are examples of energy efficient 
bulbs developed to decrease carbon dioxide production from electric power plants, 
thus lessening the greenhouse effect. One of the adverse outcomes of using efficient 
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illumination at night time is the emission of shorter wavelengths (SWLs) that further 
exacerbate the health and ecological problems associated with a new source of envi-
ronmental pollution currently known as ALAN [1–3]. Light pollution is increasing 
rapidly, resulting in a more illuminated world, where outdoor and indoor illumination 
sources are increasing ALAN in developed and developing countries [4, 5].
From an anthropological perspective, electric light has brought pronounced 
benefits including advancing urbanization and industrialization by increasing 
productivity, but we are also increasingly being aware of serious public health 
and ecological negative impacts emerging from disrupting the adaptive temporal 
organization of biological responses [6–8]. Certainly, multiple studies have shown 
the effects of light pollution on social, behavioral, physiological, and molecular 
responses in many different taxa, including insects [9], fishes [10], amphibians 
[11], reptiles [12], birds [13], and mammals [14], as well as plants [15]. Some of the 
most disturbing effects of ALAN on health are metabolic dysfunction and cancer 
progression [2, 16]. In mice and humans, several lines of evidence suggest a close 
association between ALAN levels and both obesity and breast cancer progression 
[17–19]. Here, we focus on ALAN as a novel environmental polluter that disrupts 
biological timing (temporal organization) and consequently may provoke severe 
health risk, particularly breast cancer development through epigenetic modifica-
tions. First, the mammalian photoperiodic system is reviewed in relation to light 
perception and downstream endocrine responses for timing biological rhythms. 
Thereafter, we discuss the sensitivity of the photoperiodic system to the spectral 
composition of ALAN, particularly SWL illuminations. We further discuss the 
ALAN signal transduction pathway involved in melatonin suppression and aberrant 
epigenetic modifications in breast cancer progression. Therefore, melatonin and 
epigenetics are suggested as new biomarkers for breast cancer prevention. Finally, 
melatonin and thyroxin treatments in the diurnal fat sand rat (Psammomys obesus) 
are discussed in relation to their potential role in mediating the environmental 
exposures at the molecular level via epigenetic modifications, particularly global 
DNA methylation (GDM).
2. The mammalian photoperiodic system
In an early study, it has been demonstrated that the blind mole rat (Spalax 
ehrenbergi) responded differently to short and long photoperiod manipulations in 
regard to its capability to cope with low ambient temperature exposure [20]. Results 
of a more recent study on S. ehrenbergi manifested robust and differential responses 
in metabolism, stress, and melatonin levels to ALAN of different spectral com-
positions and acclimation duration [21]. These results suggested that the vestigial 
retina of this species still expresses photoreceptors that are involved mainly in 
nonvisual response. Currently, the mammalian eye is described as a dual-function 
organ, expressing photoreceptors for both visual and nonvisual responses [22]. The 
visual response is mediated by two distinct photoreceptor types, rods and cones, 
which control scotopic vision and photopic vision, respectively [23]. The nonvisual 
responses are mainly mediated by intrinsically photosensitive retinal ganglion cells 
(ipRGCs) that express the photopigment melanopsin. Even though the ipRGCs are 
connected with rods and cones by bipolar cells, they mediate nonvisual responses 
including photo-entrainment of biological rhythms [24].
First, photoperiodic signals are perceived by ipRGCs that express the photo-
pigment melanopsin [25]. The detected environmental light signal by the ipRGCs 
synchronizes the master circadian clock located in the mammalian hypothalamic 
suprachiasmatic nucleus (SCN) by the retinohypothalamic tract (RHT). The 
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SCN regulates the synthesis and release of the hormone melatonin by the pineal 
gland through multiunit sympathetic nerves from the superior cervical ganglion 
(SCG). The SCG presynaptic sympathetic terminals release noradrenalin that 
interacts with postsynaptic α- and β-adrenergic receptors to regulate synthesis and 
release of pineal melatonin [26]. In mammals, the activity of the adrenergic SCG 
terminals that innervate the pineal gland is stimulated by darkness and inhibited 
by light [27]. Under dark conditions, stimulation of the pineal adrenergic recep-
tors increases cellular cAMP levels leading to the activation of aryl-alkyl-amine-
N-acetyltransferase (AA-NAT), a key enzyme in melatonin synthesis [28]. The 
nocturnal increase in the enzymatic activity of AA-NAT is strongly inhibited by 
light exposure, consequently leading to a rapid decrease in nocturnal melatonin 
levels [29]. The pinealocytes are the primary neuroendocrine cells that synthesis 
melatonin by sequential hydroxylation and decarboxylation of its precursor 
tryptophan to serotonin. Thereafter, serotonin is acetylated by the rate-limiting 
enzyme AA-NAT and methylated by the enzyme hydroxyindole-O-methyltrans-
ferase (HIOMT) to the final product of melatonin [28, 30]. Finally, the activity of 
both AA-NAT and HIOMT is under photoperiodic control at the transcriptional 
level showing distinct diurnal rhythms with peak levels during night and nadir 
levels during the day [31].
3. Melatonin suppression as an indicator of SWL pollution
In most mammals, no level of light exposure is powerless regarding melatonin 
suppression and even low intensity and short-term exposures can reduce its pro-
duction and lead to decreased circulating levels [32, 33]. Nonetheless, melatonin 
suppression is strongly wavelength- and irradiance-dependent, with faster and 
more robust response at the SWL end of the visible spectrum below 500 nm [19, 
34, 35]. A large-scale study comparing the effect of different light technologies 
on melatonin production in humans demonstrated that the strongest suppression 
occurred in response to 4000 and 5000 K LED lights compared with incandescent, 
halogen, and fluorescent counterpart lightening systems [36]. Narrow bandwidth 
blue LED exposure (λ = 469 nm, ½ peak bandwidth = 26 nm) decreased melatonin 
levels in an irradiance dose-dependent manner, and this light was more effective in 
decreasing the hormone levels compared with that of 4000 K of white fluorescent 
at twice the energy of the latter [37]. In horses, 1 h exposure of 3 lux SWL blue light 
(468 nm) administered only to one eye was sufficient to decrease melatonin levels 
compared with control animals [38].
Furthermore, blue LED pulses (2-s pulse every 1 min for 1 h, λ = 450 nm) 
administrated through closed human eyelids markedly suppressed nocturnal 
melatonin levels and delayed the melatonin onset phase [39–41]. While the eyelids 
can weaken irradiance and wavelength ([42], light signals can still penetrate them, 
be detected by the retinal photoreceptors, and affect circadian regulation [43]. In 
humans, blue LED exposure (40 lux, 470 nm) emitted from display screens (tablets 
and computers), suppressed nocturnal melatonin in a duration-dependent man-
ner [44, 45] and melatonin suppression showed higher sensitivity to wavelength 
compared with intensity manipulations [46].
Together, it is clear that the adverse effects of light pollution are strongly mani-
fested by the SWL portion of the spectrum. As the LED illumination is becoming 
ubiquitous in every aspect of our modern life, the expected increase in light pollu-
tion may exacerbate the problem since higher irradiance and shorter wavelengths 
would be emitted by the energy efficient technology [47, 48]. Accordingly, the 
American Medical Association [49] passed a resolution in 2016 calling upon 
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communities in the USA to avoid using LED lighting in public domains as it is 
enriched with SWL [49]. In summary, SWL-ALAN is a source of pollution and 
should be removed from public spaces through legislation.
4.  ALAN as an environmental change and a model for studying 
epigenetic modifications
The flexibility and the sensitivity of the endocrine system play an adaptive 
role in determining the success and survival of organisms under contentiously 
changing environmental conditions in their habitat [50]. As the endocrine system 
regulates several functions, it is expected to be the first system to respond to 
environmental changes such as ALAN by coordinating body functions to maintain 
homeostasis during the exposure. The core stimulus-response of the endocrine 
system to ALAN relies on four main components, including the pineal gland, 
the hypothalamic-pituitary-gonadal (HPG) axis, the hypothalamic-pituitary-
thyroid axis (HPT), and the hypothalamic-pituitary-adrenal (HPA) axis [51]. 
The elaborated hormonal responses generated by these axes to ALAN exposure 
might be mediated by transcriptional regulation of gene expression via epigenetic 
modifications [52]. Therefore, epigenetic-elicited alteration in gene expression is 
a potential transduction pathway by which hormonal responses (e.g., melatonin) 
may mediate environmental exposures (e.g., ALAN). Conversely, the ALAN-
induced alteration in melatonin rhythms may also exert endocrine responses via 
epigenetic modifications [53].
The incidences of breast and prostate cancers show close association with light 
pollution particularly in urbanized and industrialized regions [2, 54]. Several 
epidemiological studies have found direct association between light pollution and 
incidence of breast cancer in women as well as prostate cancer in men [18, 55, 56]. 
Furthermore, the strong association between light pollution and cancer incidences 
displays divergent spatial disruption with higher incidences in urban compared 
with rural regions [57, 58]. Evidence for direct association between ALAN and 
cancer development comes also from animal studies.
In rats, ALAN exposure accelerated the growth rates of induced-tumors, includ-
ing mammary cancer [59–62]. Studies under control conditions demonstrated that 
30-min ALAN per midnight emitted from either white fluorescent or blue LED 
illuminations can accelerate tumor growth and lung metastatic activity in female 
BALB/c mice inoculated with 4T1 mammary carcinoma [63, 64]. Indeed, the effects 
of ALAN on tumor growth have been demonstrated at different spectral composi-
tions with markedly higher cancer burden in response to lighting exposure lower 
than 500 nm [19].
These studies have related the increased cancer burden to aberrant epigenetic 
modifications, particularly advanced global DNA hypo-methylation. Promoter 
hyper-methylation of cancer suppresser genes and global DNA hypo-methylation 
are characterizing epigenetic patterns in breast cancer cells [65, 66]. These aber-
rant epigenetic modifications may contribute to increase cancer burden by elicit-
ing genomic instability and activation of both oncogenes and metastatic related 
genes, as well as silencing tumor suppressor genes. Generally, prominent decreased 
methylation in repetitive DAN elements is a common trait in most cancer cells 
[67]. Demethylation of pro-metastatic genes is normally suppressed by DNA 
methylation and might advance gene overexpression leading to genetic instability 
that increases the risk of developing cancer [68, 69]. DNA hypomethylation can 
be detected at an early stage of breast cancer and is correlated with the degree of 
tumor differentiation [70, 71]. Altogether, the close association between aberrant 
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DAN hypomethylation and tumorigenesis, particularly of breast cancer, is well-
established, but the underlying mechanism remains poorly understood, especially 
how the adverse ALAN effects are mediated.
5.  Melatonin as a mediating signal linking ALAN and epigenetic-induced 
cancer
Since the melatonin hypothesis was first proposed during the late twentieth cen-
tury by Stevens [72], multiple studies in human and nonhuman animals have provided 
direct and indirect evidence that melatonin suppression by ALAN could impose health 
risks, including metabolic disorders and cancer progression [2, 54]. The importance 
of melatonin in the regulation of several biological functions depends heavily on its 
lipophilic and hydrophilic traits that make it omnipresent in all cell compartments, 
principally in the nucleus [73]. Indeed, low levels of 6-sulfatoxymelatonin (6-SMT), 
the major metabolites of the hormone in urine [74], have been demonstrated to 
correlate with increased risk of breast cancer in postmenopausal women [75–77]. 
Furthermore, women with blindness or long sleep duration (elevated melatonin levels) 
present reduced breast cancer risk relative to normal women [78, 79].
Physiological blood concentration of melatonin blocked human leiomyosarcoma 
(soft tissue sarcoma) proliferation by inhibiting tumor metabolic and genetic 
pathways presumable by suppression of cellular cAMP levels via melatonin receptor 
[80]. In hepatocellular carcinoma-induced mice, melatonin treatment suppressed 
tumor cell proliferation through arresting the cell cycle [81]. The metastatic activ-
ity of oral squamous cell carcinoma was notably reduced by melatonin-mediated 
inhibition of tumor-associated neutrophils [82], inflammatory cells involved in 
promoting several solid tumors [83]. Similarly, the anti-oncogenic property of 
melatonin has been demonstrated also in other cancer types, including lung [84], 
gastric [85], ovarian [86], and colon [87], as well as breast cancers [88].
Melatonin could mediate its effects of cancer development via epigenetic 
modifications, particularly GDM [89]. Melatonin treatment to MCF-7 cell lines 
significantly increased DNA methylation that was associated with increased tran-
scriptional levels of the tumor metastasis suppressor gene glypican-3 and decreased 
expression levels of the oncogenes EGR3 and POU4F2/Brn-3b [90]. In estrogen-
receptor-related breast cancer, melatonin may decrease transcriptional levels of 
the aromatase gene (involved in the regulation of estrogen synthesis) by either 
methylation of the gene or deacetylation of the promoter gene [91]. Additionally, 
nocturnal melatonin treatment can rectify the induced DNA demethylation, tumor 
growth, and metastatic activity by both blue LED and fluorescent ALAN in 4T1 
mammary cancer cell-inoculated female BALB/c mice [63, 64]. In a more recent 
study that evaluated the effects of ALAN and melatonin treatment at different 
spectral compositions in 4T1-inoculated BALB/c mice, a tissue-specific response in 
GDM was detected [19]. In this study, the tumor tissue manifested the most promi-
nent changes in GDM showing an inverse wavelength-dependent correlation that 
was reversed by melatonin. Conversely, other tissues (e.g., lung, liver, and spleen) 
showed mixed results of positive, negative, or indifferent correlation between 
methylation levels and both wavelength and melatonin treatments [19]. Largely, 
melatonin may regulate epigenetic modifications in a number of tumor-related 
genes mainly by DNA methylation, but other modifications are also possible.
The strong association between ALAN, DNA hypo-methylation, and melato-
nin suppression may be of significant clinical importance. DNA methylation and 
melatonin can be utilized as biomarkers for detecting and preventing breast cancer 
development. The traditional diagnosis method for breast cancer is scanning by 
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epigenetic modifications
The flexibility and the sensitivity of the endocrine system play an adaptive 
role in determining the success and survival of organisms under contentiously 
changing environmental conditions in their habitat [50]. As the endocrine system 
regulates several functions, it is expected to be the first system to respond to 
environmental changes such as ALAN by coordinating body functions to maintain 
homeostasis during the exposure. The core stimulus-response of the endocrine 
system to ALAN relies on four main components, including the pineal gland, 
the hypothalamic-pituitary-gonadal (HPG) axis, the hypothalamic-pituitary-
thyroid axis (HPT), and the hypothalamic-pituitary-adrenal (HPA) axis [51]. 
The elaborated hormonal responses generated by these axes to ALAN exposure 
might be mediated by transcriptional regulation of gene expression via epigenetic 
modifications [52]. Therefore, epigenetic-elicited alteration in gene expression is 
a potential transduction pathway by which hormonal responses (e.g., melatonin) 
may mediate environmental exposures (e.g., ALAN). Conversely, the ALAN-
induced alteration in melatonin rhythms may also exert endocrine responses via 
epigenetic modifications [53].
The incidences of breast and prostate cancers show close association with light 
pollution particularly in urbanized and industrialized regions [2, 54]. Several 
epidemiological studies have found direct association between light pollution and 
incidence of breast cancer in women as well as prostate cancer in men [18, 55, 56]. 
Furthermore, the strong association between light pollution and cancer incidences 
displays divergent spatial disruption with higher incidences in urban compared 
with rural regions [57, 58]. Evidence for direct association between ALAN and 
cancer development comes also from animal studies.
In rats, ALAN exposure accelerated the growth rates of induced-tumors, includ-
ing mammary cancer [59–62]. Studies under control conditions demonstrated that 
30-min ALAN per midnight emitted from either white fluorescent or blue LED 
illuminations can accelerate tumor growth and lung metastatic activity in female 
BALB/c mice inoculated with 4T1 mammary carcinoma [63, 64]. Indeed, the effects 
of ALAN on tumor growth have been demonstrated at different spectral composi-
tions with markedly higher cancer burden in response to lighting exposure lower 
than 500 nm [19].
These studies have related the increased cancer burden to aberrant epigenetic 
modifications, particularly advanced global DNA hypo-methylation. Promoter 
hyper-methylation of cancer suppresser genes and global DNA hypo-methylation 
are characterizing epigenetic patterns in breast cancer cells [65, 66]. These aber-
rant epigenetic modifications may contribute to increase cancer burden by elicit-
ing genomic instability and activation of both oncogenes and metastatic related 
genes, as well as silencing tumor suppressor genes. Generally, prominent decreased 
methylation in repetitive DAN elements is a common trait in most cancer cells 
[67]. Demethylation of pro-metastatic genes is normally suppressed by DNA 
methylation and might advance gene overexpression leading to genetic instability 
that increases the risk of developing cancer [68, 69]. DNA hypomethylation can 
be detected at an early stage of breast cancer and is correlated with the degree of 
tumor differentiation [70, 71]. Altogether, the close association between aberrant 
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DAN hypomethylation and tumorigenesis, particularly of breast cancer, is well-
established, but the underlying mechanism remains poorly understood, especially 
how the adverse ALAN effects are mediated.
5.  Melatonin as a mediating signal linking ALAN and epigenetic-induced 
cancer
Since the melatonin hypothesis was first proposed during the late twentieth cen-
tury by Stevens [72], multiple studies in human and nonhuman animals have provided 
direct and indirect evidence that melatonin suppression by ALAN could impose health 
risks, including metabolic disorders and cancer progression [2, 54]. The importance 
of melatonin in the regulation of several biological functions depends heavily on its 
lipophilic and hydrophilic traits that make it omnipresent in all cell compartments, 
principally in the nucleus [73]. Indeed, low levels of 6-sulfatoxymelatonin (6-SMT), 
the major metabolites of the hormone in urine [74], have been demonstrated to 
correlate with increased risk of breast cancer in postmenopausal women [75–77]. 
Furthermore, women with blindness or long sleep duration (elevated melatonin levels) 
present reduced breast cancer risk relative to normal women [78, 79].
Physiological blood concentration of melatonin blocked human leiomyosarcoma 
(soft tissue sarcoma) proliferation by inhibiting tumor metabolic and genetic 
pathways presumable by suppression of cellular cAMP levels via melatonin receptor 
[80]. In hepatocellular carcinoma-induced mice, melatonin treatment suppressed 
tumor cell proliferation through arresting the cell cycle [81]. The metastatic activ-
ity of oral squamous cell carcinoma was notably reduced by melatonin-mediated 
inhibition of tumor-associated neutrophils [82], inflammatory cells involved in 
promoting several solid tumors [83]. Similarly, the anti-oncogenic property of 
melatonin has been demonstrated also in other cancer types, including lung [84], 
gastric [85], ovarian [86], and colon [87], as well as breast cancers [88].
Melatonin could mediate its effects of cancer development via epigenetic 
modifications, particularly GDM [89]. Melatonin treatment to MCF-7 cell lines 
significantly increased DNA methylation that was associated with increased tran-
scriptional levels of the tumor metastasis suppressor gene glypican-3 and decreased 
expression levels of the oncogenes EGR3 and POU4F2/Brn-3b [90]. In estrogen-
receptor-related breast cancer, melatonin may decrease transcriptional levels of 
the aromatase gene (involved in the regulation of estrogen synthesis) by either 
methylation of the gene or deacetylation of the promoter gene [91]. Additionally, 
nocturnal melatonin treatment can rectify the induced DNA demethylation, tumor 
growth, and metastatic activity by both blue LED and fluorescent ALAN in 4T1 
mammary cancer cell-inoculated female BALB/c mice [63, 64]. In a more recent 
study that evaluated the effects of ALAN and melatonin treatment at different 
spectral compositions in 4T1-inoculated BALB/c mice, a tissue-specific response in 
GDM was detected [19]. In this study, the tumor tissue manifested the most promi-
nent changes in GDM showing an inverse wavelength-dependent correlation that 
was reversed by melatonin. Conversely, other tissues (e.g., lung, liver, and spleen) 
showed mixed results of positive, negative, or indifferent correlation between 
methylation levels and both wavelength and melatonin treatments [19]. Largely, 
melatonin may regulate epigenetic modifications in a number of tumor-related 
genes mainly by DNA methylation, but other modifications are also possible.
The strong association between ALAN, DNA hypo-methylation, and melato-
nin suppression may be of significant clinical importance. DNA methylation and 
melatonin can be utilized as biomarkers for detecting and preventing breast cancer 
development. The traditional diagnosis method for breast cancer is scanning by 
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mammography, which is a useful technique to identify the growth of cancer. The 
mammography cannot predict risk for breast cancer as it indicates its existence, 
but trends in melatonin suppression and DNA methylation can provide a simple, 
noninvasive, and reliable tool for predicting cancer risk, particularly among a group 
of high-risk individuals for developing the disease such as night shift workers. 
Bearing in mind that epigenetic modifications are reversible [92], early treatment 
by melatonin or any other analogs [93] for individuals at high risk can be very 
effective in preventing breast cancer. We are aware today, that genetics factors such 
as breast cancer genes are not the major causes of the malignancy and other external 
factors are heavily involved. Therefore, much more attention should be given to 
environmental changes that link endocrinology with epigenetic modifications.
Collectively, in diurnal humans, circadian disruption enforced by activity 
impinging on the inactive period during the nighttime is recurrently associated 
with a number of health problems. However, a direct link between ALAN-induced 
circadian disruption and health risks is still difficult to clearly establish as most data 
are derived from epidemiological and nocturnal animal studies [94]. Therefore, 
integrating diurnal animal models of chronodisruption with epidemiological and 
nocturnal model studies would add a significant value in defining potential direct 
signal transduction pathways mediating the environmental exposure impacts on 
physiology and health. Consequently, we conducted a preliminary study to investi-
gate the effects of hormonal manipulations in diurnal species on physiological and 
epigenetic regulations. This preliminary study is a first step in a large-scale study 
using diurnal mouse model to elucidate the association between ALAN-induced 
circadian disruption and the development of health problems at the behavioral, 
physiological, and molecular levels.
6.  Physiological and epigenetic responses to melatonin and thyroxin in 
diurnal species
Bearing in mind that humans are diurnal, understanding the physiological 
and epigenetic response to ALAN in human disease can benefit significantly from 
using a diurnal species such as the fat sand rat (Psammomys obesus). This species 
is a good model because it is a photoperiodic species that responds to photoperiod 
with robust daily rhythms in a number of physiological functions, including body 
temperature, melatonin levels, and AA-NAT activity [95, 96]. Furthermore, P. 
obesus is a useful model for studying human health and diseases such as meta-
bolic disorders, obesity, diabetes, inflammation, and cardiovascular impairment 
[97–100]. Since most previous studies on photoperiodic responses were conducted 
on nocturnal species, in our research center at the University of Haifa, we use P. 
obesus as a model for studying photoperiodic and hormonal manipulations. In P. 
obesus, melatonin and body temperature rhythms were diminished in response 
to constant dim blue light exposure, while melatonin treatment restored the 
disrupted rhythms [63]. Although the previous studies have clearly indicated that 
as a diurnal species, P. obesus can respond to photoperiod and light manipulations, 
the underling mechanism mediating the effect of the environmental changes 
remains unknown. An unanswered question is how melatonin and thyroxin inter-
act to mediated environmental-induced epigenetic modifications. To answer this 
question, male P. obesus were acclimated to a long photoperiod cycle of 16L:8D at 
an ambient temperature of 24 ± 1°C and humidity of 45 ± 2%. Lights during the 
day were emitted from cool fluorescent lamps at 470 lux and 470 nm. Rats were 
caged individually and provided with ad libitum tap water and low energy diet. 
At the end of 3-week acclimation period, rats were either untreated, i.p. injected 
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with melatonin, thyroxin, or melatonin and thyroxin in combination 3 h after the 
dark period onset (01:00 h). Hormones were daily administered for 3 weeks at a 
dose of 50 μg/kg for melatonin and 2 mg/kg for thyroxin. During the experimen-
tal period, body mass (Wb) was monitored every other day and urine samples 
were collected by a noninvasive method [19] at 4 h intervals over a 28 h period. 
Urine samples were used to measure the major metabolite of melatonin in urine, 
6-SMT [101]. The urinary metabolite concentrations were assayed by enzyme-
linked immunosorbent assay utilizing a commercial IBL kit (RE54031) following 
the manufacture’s protocol. Finally, digit tips were collected from rats at the end 
of urine collection for DNA isolation (High pure PCR Template Preparation Kit, 
Roche) and subsequently for GDM analysis (MethylFlash™ Methylated DNA 
Quantification Kit, Epigentek). All experimental procedures were performed 
with the approval from the Ethics and Animal Care Committee of the University 
of Haifa.
The results showed that melatonin alone significantly increased Wb from day 1 
compared with controls, but with a decreasing magnitude with time (Figure 1A). 
Mass gain on day 1 was approximately 1.5-fold higher compared with that at the last. 
T4 also increased Wb from day 1 to day 5 compared with controls, but with signifi-
cantly lesser effect compared with melatonin. Thereafter, mass was decreased show-
ing a moderate mass loss from day 13 to day 21 compared with controls. Thyroxin 
and melatonin in combination markedly decreased Wb with time compared with all 
other groups. Mass gain decreased from 0.46 ± 0.88% at day 1 to −20.21 ± 2.56% at 
day 21. Thyroxin can regulate Wb by increasing heat production through nonshiver-
ing thermogenesis by changing membrane permeability to sodium, increasing the 
pump activity to maintain cell homeostasis in brown adipose tissue, resulting in 
higher body temperature values and loss in Wb [102].
Melatonin may operate through increasing the amount of brown adipose tissue, 
thus increasing heat production by increasing energy expenditure. Melatonin and 
thyroxin in combination provoked considerably more mass loss than melatonin 
alone, suggesting that melatonin may act synergistically with thyroxin to evoke 
mass loss in rats, due to the combined effect of increasing energy expenditure.
Body temperature rhythms were notably altered only in response to T4 treat-
ment, while melatonin alone and in combination with thyroxin had no effect on 
body temperature compared with controls (Figure 1B). Furthermore, the signifi-
cant decrease in body temperature following treatments with thyroxin and melato-
nin in combination, compared with T4 alone, suggests that melatonin and thyroxin 
exert a significant antagonistic effect on body temperature.
Thyroxin treatment had no effect on mean 6-SMT levels but altered the daily 
rhythms with higher amplitude and delayed acrophase by approximately 2 h 
(Figure 2A). Finally, melatonin treatment elicited hypomethylation while thyroxin 
alone or thyroxin and melatonin in combination exerted comparable effects on 
GDM levels showing marked hypermethylation compared with control levels 
(Figure 2B). Similar to Wb, thyroxin and melatonin may have exerted synergistic 
effects on promoting DNA hypermethylation, but this effect did not reach statisti-
cal significance.
These results suggest that melatonin and thyroxin have a role in the regulation of 
body temperature and apparently metabolism, in which the former may attenuate 
metabolism and the latter may accelerate it. Both hormones exerted inverse effects 
on global DNA levels, suggesting that different transduction pathways are involved 
in the circadian regulation of body temperature in P. obesus. The results suggest 
also that change in body temperature is more sensitive to thyroxin treatment than 
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However, in humans, melatonin may interact with the HPT axis to modulate 
the circadian rhythm of body temperature [104]. In mammals, the HPT axis plays 
a major role in several adaptive functions such as growth, development, metabolic 
rate, thermogenesis, heart rate, immune, and reproductive responses [105]. The 
HPT releasing and stimulating hormones as well as the thyroid hormones (T4 
and T3) are under photoperiodic control presumably by the pars tuberalis of the 
adenohypophysis [106, 107]. In rats, T3 and T4 concentrations exhibit significant 
circadian rhythms with elevated levels during the dark period compared with the 
counterpart light period [108]. The nocturnal increase in the thyroid hormones was 
reported also in the rat pineal gland following an increase in type I 5′-iodothyronine 
deiodinase activity, which catalyzes the conversion of T4 to T3 [109]. Furthermore, 
the thyroid hormones are crucial photoperiodic regulators of several physiological 
Figure 1. 
Percentage change in body mass (A) and body temperature (B) in long-day acclimated P. obesus under four 
conditions: control no treatments, thyroxin (T4) treatment, melatonin (MLT) treatment, and combined treatment 
with T4 + MLT. Data are presented as mean ± standard error of nine animals. Different letters represent 
statistically significant difference among groups (Bonferroni, P < 0.01). # vs. day 21 (Bonferroni, P < 0.02).
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processes including energy metabolism and reproduction [110, 111]. While the 
relation between the HPT axis and the photoperiodic system are well-characterized, 
there are limited studies on the effect of ALAN on the HPT axis. However, due 
to the link with the photoperiodic system, environmental perturbation of the 
circadian clock by ALAN is expected to alter the activity of the HPT axis, includ-
ing the thyroid hormones. In hamsters under short-day photoperiod, low levels of 
ALAN elevated the levels of thyroid-stimulating-hormone (TSH) receptors causing 
advanced Wb and gonadal growth [112]. Continuous exposure to ALAN decreased 
Figure 2. 
Daily rhythms of urinary 6-sulfatoxymelatonin (A) and global DNA methylation (B) levels in long-day 
acclimated P. obesus under four conditions: control no treatments, thyroxin (T4) treatment, melatonin (MLT) 
treatment, and combined treatment with T4 + MLT. In panel A, the best-fitted cosine curve (black and gray 
lines) and Cosinor estimates (period, P-value, and percentage of the rhythm [PR]) are depicted [103]. The gray 
area in each plot represents the length of the dark period. Data are presented as mean ± standard error of seven to 
nine animals. Different letters represent statistically significant difference among groups (Bonferroni, P < 0.01).
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TSH, but increased both T3 and T4 in mice [113]. In birds, long-term exposure 
to ALAN increased both the blood levels of the thyroid hormones and Wb [114]. 
Overall, ALAN may induce aberrant epigenetic modifications by disrupting endo-
crine axes such as HPT axis that interacts with melatonin to manifest the adverse 
effects of the environmental exposure. However, the exact mechanism of action by 
which HPT axis may directly, or via melatonin, mediate the disruption effects of 
ALAN on the circadian system and promote downstream health risk is still unclear, 
and further efforts are warranted for elucidating it.
7. Conclusions
Currently, it is clear that electric light not only has remarkable anthropological 
advantages, but also severe adverse ecological and public health concerns. One of the 
most alerting impacts of ALAN on public health is the potential association between 
SWL exposure and cancer development, particularly in urbanized regions worldwide. 
ALAN effects are suggested to be mediated at the cellular level by inducing epigenetic 
modifications via nocturnal melatonin suppression. A schematic of ALAN-induced 
adverse effects is presented in Figure 3. Accordingly, light signals including ALAN 
are detected by ipRGCs and conveyed to the SCN by RHT. During a normal light dark 
cycle, melatonin is synthesized and secreted to the blood during the night, where it 
entrains central and peripheral oscillators to regulate normal physiological responses. 
Conversely, ALAN suppresses melatonin levels causing chronodisruption and mis-
alignment in central and peripheral oscillators resulting in impaired physiological 
responses. The central and peripheral oscillators can be regulated directly by the mela-
tonin signal or indirectly by modifying the body temperature rhythms [115]. In mice, 
daily variations in body temperature rhythms have been demonstrated to synchronize 
circadian gene expressions [116] and these central-controlled variations can be utilized 
to regulate variant peripheral circadian clocks in mammals [117]. Consequently, in 
diurnal species, thyroxin as an endocrine pathway is presumably involved in center cir-
cadian regulation of peripheral clocks by modifying body temperature daily rhythms.
These effects are presumably mediated by aberrant epigenetic modifications. 
Therefore, DNA methylations, which are a reversible modification in genes, trig-
gered by melatonin, are a promising mechanism linking between environmental 
exposures like ALAN and hormonal/cellular pathway mediating carcinogenic activi-
ties like metastasis activity, tumor cell proliferation, and estrogen-related responses 
[89]. Melatonin may affect DNA methylation by modulating the activity of DNA 
methyltransferases involved in the regulation of gene expression by changing DNA 
methylation patterns. The well-established fact that different tissues present specific 
patterns of epigenetic modifications [118] may account for the observed tissue-spe-
cific effects of ALAN and melatonin on DNA methyl-transferase activity and GDM 
levels. Tissue differential effects on the activity of DNA methyl-transferases and 
GDM levels in response to ALAN exposure may present tissue-specific responses 
to genes that are involved in circadian regulation of several transduction pathways 
including cancer cell proliferation and metastatic activity. Since humans are diurnal 
species and most studies have been conducted on nocturnal animals, a diurnal 
experimental model should be of a great clinical interest. P. obesus may be very 
useful as a diurnal animal model for understanding the physiological and molecular 
effects of light pollution on public health. Melatonin suppression, GDM, and even 
thyroxin levels may present a significant clinical importance as a biomarker for 
early detection of cancer, particularly in individuals who are at increased risk of 
developing cancer by circadian disruption induced by excessive ALAN exposures. 
As epigenetic modifications are revisable, these biomarkers retain therapeutic value 
53
Consequences of Artificial Light at Night: The Linkage between Chasing Darkness Away…
DOI: http://dx.doi.org/10.5772/intechopen.84789
for ALAN-induced cancer by gene demethylation. Finally, the accumulating data 
regarding the adverse effects of light pollution on ecology and heath compel us to 
take drastic and rapid measures to reduce light pollution by extreme regulation or at 
least reducing SWL emission by developing safe lightning technology.
Figure 3. 
Schematic representation of the mechanism of ALAN in eliciting adverse health effects. Light signal, including 
short wavelength ALAN (SWL-ALAN), is detected by intrinsically photosensitive retinal ganglion cells 
(ipRGCs) that propagate it to the SCN via the retinohypothalamic tract (RHT). Thereafter, the signal is 
transmitted to the pineal gland (PG) via superior cervical ganglion (SCG). Finally, melatonin is synthesized 
and secreted to circulation by the PG during the night, where it synchronizes peripheral clocks with the ambient 
photoperiod. Generally, ALAN suppresses nocturnal melatonin, in which adverse health impacts are generated 
by inducing aberrant epigenetic modifications.
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effects of the environmental exposure. However, the exact mechanism of action by 
which HPT axis may directly, or via melatonin, mediate the disruption effects of 
ALAN on the circadian system and promote downstream health risk is still unclear, 
and further efforts are warranted for elucidating it.
7. Conclusions
Currently, it is clear that electric light not only has remarkable anthropological 
advantages, but also severe adverse ecological and public health concerns. One of the 
most alerting impacts of ALAN on public health is the potential association between 
SWL exposure and cancer development, particularly in urbanized regions worldwide. 
ALAN effects are suggested to be mediated at the cellular level by inducing epigenetic 
modifications via nocturnal melatonin suppression. A schematic of ALAN-induced 
adverse effects is presented in Figure 3. Accordingly, light signals including ALAN 
are detected by ipRGCs and conveyed to the SCN by RHT. During a normal light dark 
cycle, melatonin is synthesized and secreted to the blood during the night, where it 
entrains central and peripheral oscillators to regulate normal physiological responses. 
Conversely, ALAN suppresses melatonin levels causing chronodisruption and mis-
alignment in central and peripheral oscillators resulting in impaired physiological 
responses. The central and peripheral oscillators can be regulated directly by the mela-
tonin signal or indirectly by modifying the body temperature rhythms [115]. In mice, 
daily variations in body temperature rhythms have been demonstrated to synchronize 
circadian gene expressions [116] and these central-controlled variations can be utilized 
to regulate variant peripheral circadian clocks in mammals [117]. Consequently, in 
diurnal species, thyroxin as an endocrine pathway is presumably involved in center cir-
cadian regulation of peripheral clocks by modifying body temperature daily rhythms.
These effects are presumably mediated by aberrant epigenetic modifications. 
Therefore, DNA methylations, which are a reversible modification in genes, trig-
gered by melatonin, are a promising mechanism linking between environmental 
exposures like ALAN and hormonal/cellular pathway mediating carcinogenic activi-
ties like metastasis activity, tumor cell proliferation, and estrogen-related responses 
[89]. Melatonin may affect DNA methylation by modulating the activity of DNA 
methyltransferases involved in the regulation of gene expression by changing DNA 
methylation patterns. The well-established fact that different tissues present specific 
patterns of epigenetic modifications [118] may account for the observed tissue-spe-
cific effects of ALAN and melatonin on DNA methyl-transferase activity and GDM 
levels. Tissue differential effects on the activity of DNA methyl-transferases and 
GDM levels in response to ALAN exposure may present tissue-specific responses 
to genes that are involved in circadian regulation of several transduction pathways 
including cancer cell proliferation and metastatic activity. Since humans are diurnal 
species and most studies have been conducted on nocturnal animals, a diurnal 
experimental model should be of a great clinical interest. P. obesus may be very 
useful as a diurnal animal model for understanding the physiological and molecular 
effects of light pollution on public health. Melatonin suppression, GDM, and even 
thyroxin levels may present a significant clinical importance as a biomarker for 
early detection of cancer, particularly in individuals who are at increased risk of 
developing cancer by circadian disruption induced by excessive ALAN exposures. 
As epigenetic modifications are revisable, these biomarkers retain therapeutic value 
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for ALAN-induced cancer by gene demethylation. Finally, the accumulating data 
regarding the adverse effects of light pollution on ecology and heath compel us to 
take drastic and rapid measures to reduce light pollution by extreme regulation or at 
least reducing SWL emission by developing safe lightning technology.
Figure 3. 
Schematic representation of the mechanism of ALAN in eliciting adverse health effects. Light signal, including 
short wavelength ALAN (SWL-ALAN), is detected by intrinsically photosensitive retinal ganglion cells 
(ipRGCs) that propagate it to the SCN via the retinohypothalamic tract (RHT). Thereafter, the signal is 
transmitted to the pineal gland (PG) via superior cervical ganglion (SCG). Finally, melatonin is synthesized 
and secreted to circulation by the PG during the night, where it synchronizes peripheral clocks with the ambient 
photoperiod. Generally, ALAN suppresses nocturnal melatonin, in which adverse health impacts are generated 
by inducing aberrant epigenetic modifications.
Epigenetics
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A Hypothesis to Explain How 
the DNA of Elderly People Is 
Prone to Damage: Genome-
Wide Hypomethylation Drives 
Genomic Instability in the Elderly 




Epigenetic changes are how the DNA of elderly people is prone to damage. 
One role of DNA methylation is to prevent DNA damage. In the elderly and those 
with aging-associated noncommunicable diseases (NCDs), DNA shows reduced 
methylation; consequently, the aging genome is unstable and accumulates 
DNA damage. While the DNA damage response (DDR) of the direct intracel-
lular machinery repairs DNA lesions, too much DDR halts cell proliferation, 
and promotes senescence. Therefore, genome-wide hypomethylation drives 
genomic instability, causing aging-associated disease phenotypes. However, the 
mechanism is unknown. Independent of DNA replication, the eukaryotic genome 
retains a certain amount of endogenous DNA double-strand breaks (EDSBs), 
called physiologic replication-independent EDSBs (Phy-RIND-EDSBs), that 
possess physiological function. Phy-RIND-EDSBs are reduced in aging yeast, 
and low levels of Phy-RIND-EDSBs decrease cell viability and increase DNA 
damage. Thus, Phy-RIND-EDSBs have a biological role as youth-associated 
genomic-stabilizing DNA gaps. In humans, Phy-RIND-EDSBs are located in the 
hypermethylated genome. Because the genomes of aging people are hypometh-
ylated, the elderly should also have a low level of Phy-RIND-EDSBs. Based on 
this evidence, I hypothesize that in the human Phy-RIND-EDSBs, reduction is 
a molecular process that mediates the genome-wide hypomethylation driving 
genomic instability, which is a nidus pathogenesis mechanism of human body 
deterioration in aging-associated NCDs.
Keywords: genome-wide hypomethylation, genomic instability, global 
hypomethylation, DNA damage, youth-associated genomic-stabilizing DNA 
gaps, youth-DNA-GAPs, physiological replication-independent endogenous DNA 
double-strand breaks, RIND-EDSBs, Phy-RIND-EDSBs, aging
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the DNA of Elderly People Is 
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Epigenetic changes are how the DNA of elderly people is prone to damage. 
One role of DNA methylation is to prevent DNA damage. In the elderly and those 
with aging-associated noncommunicable diseases (NCDs), DNA shows reduced 
methylation; consequently, the aging genome is unstable and accumulates 
DNA damage. While the DNA damage response (DDR) of the direct intracel-
lular machinery repairs DNA lesions, too much DDR halts cell proliferation, 
and promotes senescence. Therefore, genome-wide hypomethylation drives 
genomic instability, causing aging-associated disease phenotypes. However, the 
mechanism is unknown. Independent of DNA replication, the eukaryotic genome 
retains a certain amount of endogenous DNA double-strand breaks (EDSBs), 
called physiologic replication-independent EDSBs (Phy-RIND-EDSBs), that 
possess physiological function. Phy-RIND-EDSBs are reduced in aging yeast, 
and low levels of Phy-RIND-EDSBs decrease cell viability and increase DNA 
damage. Thus, Phy-RIND-EDSBs have a biological role as youth-associated 
genomic-stabilizing DNA gaps. In humans, Phy-RIND-EDSBs are located in the 
hypermethylated genome. Because the genomes of aging people are hypometh-
ylated, the elderly should also have a low level of Phy-RIND-EDSBs. Based on 
this evidence, I hypothesize that in the human Phy-RIND-EDSBs, reduction is 
a molecular process that mediates the genome-wide hypomethylation driving 
genomic instability, which is a nidus pathogenesis mechanism of human body 
deterioration in aging-associated NCDs.
Keywords: genome-wide hypomethylation, genomic instability, global 
hypomethylation, DNA damage, youth-associated genomic-stabilizing DNA 
gaps, youth-DNA-GAPs, physiological replication-independent endogenous DNA 




As people age, their bodies begin to deteriorate. Understanding how changes 
in the DNA of aging people affect cellular function will be an important clue for 
future prevention and treatment of age-associated noncommunicable diseases 
(NCDs). Genomic instability, a hallmark of cancer and aging, is defined as a 
high frequency of mutations within the genome [1, 2]. In cancer, the permanent 
alteration of the nucleotide sequence of DNA, or mutations, occurring in proto-
oncogenes and tumor suppressor genes lead to cancer development and progres-
sion. In the aging process, however, the accumulation of DNA damage, which is an 
abnormal chemical structure in DNA and includes base modification, base loss, 
and DNA breaks (which are precursors of mutations), stimulates the DNA damage 
repair signal (DDR) to induce cells to repair DNA damage [3, 4]. Nevertheless, 
DDR arrests the cell cycle, rewires cellular metabolism, promotes senescence, and 
initiates programmed cell death. As a result, too much DDR drives the cellular aging 
process [3, 4]. Accumulation of DNA damage is found in the elderly and people 
with age-associated NCDs (Figure 1) [5]. Therefore, DNA damage accumulation 
is a crucial molecular pathogenic mechanism of the aging process. However, the 
mechanism by which DNA damage spontaneously accumulates in the aging genome 
remains to be explored.
Both epigenetic marks and DNA damage or lesions are temporary modifica-
tions of DNA. However, both are produced by different mechanisms and play 
roles in genomic instability in opposite directions. Epigenetic marks are produced 
by biological processes and possess physiological functions [6, 7]. For example, 
DNA methylation or methyl CpG is produced by DNA methyltransferase. The 
molecular function of methyl CpG is to interact with a protein such as methyl-
CpG-binding protein. This interaction forms a cascade of molecular biological 
processes for gene regulation control and genomic stability. DNA lesions, on the 
other hand, are produced by endogenous or exogenous hazards [8]. For example, 
pyrimidine dimers, one type of DNA lesion, are formed via photochemical 
reactions such as exposure to UV light. DNA damage is converted into a mutation 
during subsequent replication, so accumulation of DNA damage leads to genomic 
instability. This chapter describes that genomic instability in the elderly should 
occur by the alteration of epigenetic marks leading to spontaneous accumulation 
of DNA damage.
Global DNA hypomethylation is an epigenetic change in the elderly and 
people with NCDs that promotes genomic instability [9–13]. However, the 
underlying mechanism of how the hypomethylated genome accumulates DNA 
damage is unknown [14]. In 2008, my group discovered an unprecedented type 
of endogenous DNA double-strand break (EDSB). These breaks are found in all 
cells, including nondividing cells, so we named them replication-independent 
EDSBs (RIND-EDSBs) [15]. RIND-EDSBs are located in hypermethylated 
DNA. Therefore, cells with global hypomethylation, such as cancer cells, have 
lower levels of RIND-EDSBs than noncancer cells [15]. After the discovery, we 
explored several characteristics of RIND-EDSBs and found that the majority of 
RIND-EDSBs possess physiological functions, namely, physiologic RIND-EDSBs 
(Phy-RIND-EDSBs), as epigenetic marks in maintaining genomic stability [16–19]. 
Interestingly, Phy-RIND-EDSBs in yeast decrease when yeast cells age [19]. So 
here I rename Phy-RIND-EDSBs in accordance with their role as youth-associated 
genomic-stabilizing DNA gaps (Youth-DNA-GAPs). In this chapter, we propose 
a hypothesis that the hypomethylated genome of the elderly reduces Phy-RIND-
EDSBs and that this reduction causes DNA damage. The accumulation of DNA 
damage initiates DDR and consequently drives the cellular aging process (Figure 1). 
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In other words, the reduction in Phy-RIND-EDSBs by genome-wide hypomethyl-
ation is the underlying molecular pathogenesis mechanism of aging phenotypes.
Figure 1. 
Genome-wide hypomethylation drives genomic instability in the elderly by reducing youth-associated 
genome-stabilizing DNA gaps: A hypothesis. DNA methylation in the elderly is generally reduced, genome-
wide hypomethylation. A reduction in DNA methylation leads to genomic instability, accumulation of 
endogenous DNA damage, and sensitivity to DNA-damaging agents. Here, we propose a hypothesis that global 
hypomethylation causes a reduction in Phy-RIND-EDSBs and that the reduction in Phy-RIND-EDSBs causes 
DNA damage. The accumulation of endogenous DNA damage will promote DDR, and too much DDR will 
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(NCDs). Genomic instability, a hallmark of cancer and aging, is defined as a 
high frequency of mutations within the genome [1, 2]. In cancer, the permanent 
alteration of the nucleotide sequence of DNA, or mutations, occurring in proto-
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In other words, the reduction in Phy-RIND-EDSBs by genome-wide hypomethyl-
ation is the underlying molecular pathogenesis mechanism of aging phenotypes.
Figure 1. 
Genome-wide hypomethylation drives genomic instability in the elderly by reducing youth-associated 
genome-stabilizing DNA gaps: A hypothesis. DNA methylation in the elderly is generally reduced, genome-
wide hypomethylation. A reduction in DNA methylation leads to genomic instability, accumulation of 
endogenous DNA damage, and sensitivity to DNA-damaging agents. Here, we propose a hypothesis that global 
hypomethylation causes a reduction in Phy-RIND-EDSBs and that the reduction in Phy-RIND-EDSBs causes 
DNA damage. The accumulation of endogenous DNA damage will promote DDR, and too much DDR will 




Genome-wide hypomethylation reduces the DNA methylation level of the 
whole genome. DNA methylation possesses two basic roles, gene regulation and 
the prevention of genomic instability, which we emphasize here [20]. The majority 
of DNA methylation in the human genome is on interspersed repetitive sequences 
(IRSs). Genome-wide hypomethylation or global hypomethylation mostly reflects 
a decrease in the DNA methylation of IRSs [11, 21]. Here, I will describe how IRS 
methylation occurs, how hypomethylation occurs, and how hypomethylation drives 
genomic instability in the elderly.
2.1 Interspersed repetitive sequence methylation
To evaluate the global methylation level, most recent studies have used PCR 
techniques to measure the DNA methylation level of each IRS, including Alu ele-
ments (Alu), long interspersed element-1s (LINE-1s), and several types of human 
endogenous retroviruses (HERVs). A reduction in Alu element methylation repre-
sents a genome-wide hypomethylation, driving genomic instability more than that of 
LINE-1 s and HERVs [11]. Throughout the human genome, there are over 1 million 
copies of Alu elements [22]. Although there is also a vast number of LINE-1 s, only 
approximately 3000 copies of LINE-1s contain a 5’ UTR where LINE-1 methylation 
was usually measured [23, 24]. Because there are several classes of HERVs, each PCR 
measured DNA methylation of one class and as a result, covered a smaller percentage 
of the genome [25]. Furthermore, methylation of LINE-1 and HERV was reported to 
possess gene regulation functions [24, 26]. The tissue-specific methylation level of 
LINE-1 is locus dependent [27, 28]. In contrast, the global hypomethylation occurs as 
a generalized process [11, 28]. Therefore, methylation of LINE-1 and HERV repre-
sents global methylation in a lesser proportion than that of Alu elements.
2.2 Alu hypomethylation in aging and NCDs
Although global hypomethylation has been reported in the elderly, not all IRSs 
are hypomethylated. We investigated Alu, LINE-1, and HERV-K and found Alu and 
HERV-K hypomethylation in aging but not LINE-1 [11]. Therefore, methylation of 
LINE-1 and Alu may possess different roles. Global hypomethylation is also associ-
ated with the aging phenotype. First, lower global DNA methylation is associated 
with higher cardiovascular risk in postmenopausal women [29]. Second, Alu 
hypomethylation was observed in individuals with lower bone mass, osteopenia, 
osteoporosis, and a high body mass index [12]. Finally, Alu hypomethylation was 
reported in diabetes mellitus patients and was directly correlated with high fasting 
blood sugar, HbA1C, and blood pressure [13]. Interestingly, the Alu methylation 
level was also high in catch-up growth in a 20-year-old offspring [30]. These studies 
indicated the positive role of Alu methylation in the human growth process and the 
role of Alu hypomethylation as an epigenetic cause of the human aging process.
2.3 Mechanism causing global hypomethylation
The direct correlation between IRS methylation levels suggests that the 
mechanisms causing global hypomethylation in both aging cells and cancer are a 
generalizing process [11, 28]. The actual mechanism causing global hypomethyl-
ation in aging remains to be explored. Nevertheless, exposure to oxidative stress, 
benzene, air pollution, UV light, radiation, smoke, and folate deficiency facilitates 
genome-wide hypomethylation processes [31–37]. Therefore, the accumulation of 
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DNA damage, oxidative stress, or a lack of DNA methylation precursors can lead to 
genome-wide hypomethylation.
Evidence suggests that DNA damage drives the demethylation process. DNA 
repair, which is how cells remove DNA lesions, is also a demethylation mechanism 
that directly removes 5-methylcytosine. Methylcytosine is a DNA base that is prone 
to be deaminated and must be fixed by base excision repair (BER) machinery to 
prevent cytosine-to-thymine substitution. However, BER replaces the DNA lesion 
with an unmethylated form of cytosine. As a result, the methylcytosine is demeth-
ylated. The other mechanism is to remove the entire DNA patch and refill with 
unmethylated nucleotides by nucleotide excision repair (NER) or mismatch repair 
(MMR) [38].
For oxidative stress, oxidation of 5-methylcytosine forms 5-hydroxymethyl-
cytosine. There are several mechanisms for removing 5-hydroxymethylcytosines 
and replacing them with unmethylated forms, AID/APOBEC enzymes and 
TET enzymes followed by BER [39–44]. Alternatively, oxidative stress may 
interfere with the DNA methylation protein machinery. For example, oxida-
tive stress depletes the synthesis of glutathione and decreases the availability of 
S-adenosylmethionine for DNA methylation [45]. This proposed mechanism is 
similar to DNA demethylation in depletion of the methyl pool in folate-deficient 
models [46, 47].
2.4 Hypomethylation accumulates multiple kinds of DNA lesions
The hypomethylated genome is prone to accumulating multiple kinds of DNA 
damage, which is an abnormal chemical structure in DNA and includes oxida-
tive damage, depurination, depyrimidination, and pathologic EDSBs [10, 14]. 
Alu methylation levels in white blood cells were found to inversely correlate with 
8-hydroxy-2′-deoxyguanosine (8-OHdG) oxidative damage and apurinic/apyrimi-
dinic sites (AP sites) [37]. Transfection of cells with Alu small interfering RNA  
(Alu siRNA) increased Alu methylation and reduced endogenous 8-OHdG and AP 
sites [37]. Interestingly, Alu siRNA also increased cell division and resistance to 
DNA damage-causing agents [37]. This evidence indirectly suggests that Alu meth-
ylation stabilizes the human genome. DNA methylation also prevents pathologic 
EDSBs. The chromosomal rearrangements and deletions of DNA commonly found 
in cancer cells treated with DNA demethylating agents and DNA methyltransferase 
(DNMT) knockout mice and naturally occurring mutations in the cytosine DNA 
methyltransferase DNMT3B suggest that pathologic EDSBs are the intermediate 
products of hypomethylation that drive genomic instability [10, 48–50].
2.5  DNA lesions as a molecular pathogenesis mechanism of the aging process and 
NCDs
A number of studies support the idea that accumulation of DNA damage drives 
the aging process. First, congenital defects in DNA repair accelerate aging. For 
example, progeroid syndrome patients with ERCC4 mutations have premature 
aging of many organs. ERCC4 is a protein designated as the DNA repair endonucle-
ase XPF that is critical for many DNA repair pathways, including NER [51]. Second, 
genotoxic agents accelerate the aging process in cancer survivor patients. For 
example, 50-year-old survivors of childhood cancer have an increased incidence of 
age-related diseases compared to their siblings [52]. Third, there is evidence of DNA 
damage accumulation when cells age. Pathologic EDSBs are accumulated in chrono-
logical aging yeast [17]. Many kinds of DNA damage from base modifications to 
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of animals and humans [53–56]. Finally, a reduction in DNA repair efficiency was 
reported in aging cells of many organisms [57–59]. In NCDs, the accumulation of 
oxidative DNA damage has been reported in patients with cardiovascular disease, 
diabetes and metabolic syndrome, chronic obstructive pulmonary disease, osteopo-
rosis, and neurological degeneration, including Alzheimer’s disease and Parkinson’s 
disease [5]. DNA damage triggers DDR. To facilitate DNA repair and prevent 
mutation accumulation, DDR arrests cell cycle progression until repair is complete. 
While DDR can prevent cancer development, DDR leads to many unwanted effects, 
including inflammation, metabolic rewiring, senescence, apoptosis, and aging 
[60–62]. The DDR signaling pathway consists of signal sensors, transducers, and 
effectors. The sensors of this pathway are proteins that recognize DNA damage. The 
main transducers are ATM and ATR and their downstream kinases. The effectors 
of this pathway are substrates of ATM and ATR and their downstream kinases. 
These effectors of DDR involve many proteins, including P53, BRCA1, and CDC25s 
[60–63].
2.6  DNA methylation possesses a long-range effect in stabilizing the human 
genome in cis
A direct association between loss of DNA methylation and rearrangements in 
the pericentromeric heterochromatin was demonstrated in ICF syndrome (immu-
nodeficiency, chromosomal instability, and facial anomalies) and loss-of-function 
mutations in DNMT3B [50, 64]. Therefore, hypomethylation could lead to spon-
taneous mutations in cis, which are epigenetic and genetic events occurring in the 
same chromosome. Notably, Alu siRNA increased Alu methylation levels in HEK293 
cells from 60 to 70% [14]. Because there are approximately 1 million copies of Alu, 
by rough estimation, Alu siRNA methylates 10% of Alu elements or approximately 
100,000 Alu elements in 3000 Mb of the human genome. In other words, Alu 
siRNA transfection methylated one locus of every 30 kb of human genome on aver-
age. Furthermore, Alu siRNA reduced 75% of endogenous 8-OHdG [14]. Therefore, 
even if Alu siRNA increases methylation in a limited location, the transfection 
stabilized the genome far beyond the methylated Alu elements (Figure 2).
2.7 Hypotheses: DNA methylation prevents genomic instability mechanisms
There are at least three possible mechanisms by which Alu methylation reduces 
endogenous DNA damage and increases resistance to DNA damage-causing agents. 
The extension of genomic stability from methylated Alu loci supports my first 
hypothesis that DNA methylation stabilizes the genome by homing Youth-DNA-
GAPs, Phy-RIND-EDSBs, and that the gaps extended the stabilizing effect to the 
entire genome [14]. Another reason that supports the Phy-RIND-EDSBs mediating 
the DNA methylation role in stabilizing the genome is that Phy-RIND-EDSBs are 
localized in hypermethylated DNA [15]. Moreover, Phy-RIND-EDSBs possess a 
redundant topoisomerase which relieve tension of double-helix spin and torsion 
from any DNA activity [17]. The second hypothesis would be the spreading of DNA 
methylation and consequently heterochromatin [65]. However, this mechanism is 
unlikely because the spreading would need to extend to cover the whole genome and 
would interfere with cellular function. A reduction in cell viability by Alu siRNA was 
not observed. The last and unlikely hypothesis was that DNA methylation somehow 
enhanced DNA repair activity [66], although this mechanism is also unlikely because 
most DNA repair machinery starts with specific sensors to recognize DNA lesions.
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3. Phy-RIND-EDSBs represent epigenetic marks as youth-DNA-GAPs
Phy-RIND-EDSBs are found in all eukaryotic cells, produced by certain proteins, 
and reduced in chronological aging yeast [15, 17, 19]. A reduction in Phy-RIND-
EDSBs decreased cell viability and augmented pathologic EDSB production [19]. 
Phy-RIND-EDSBs are devoid of DDR and are repaired by the error-free repair 
pathway [16]. Therefore, Phy-RIND-EDSBs are Youth-DNA-GAPs epigenetic marks 
that prevent genomic instability in eukaryotic genomes.
3.1 IRS-EDSB ligation-mediated PCR (IRS-EDSB-LMPCR) to measure EDSBs
Ligation-mediated PCR (LMPCR) is the method that we used for EDSB detec-
tion [15]. Previously, this PCR technique was used to characterize the signal end 
and coding end of EDSBs occurring during the V(D)J recombination process 
[67]. For V(D)J recombination, the signal end and coding end of EDSBs occur 
at the T-cell receptor or antibody genes in lymphoblasts. To detect the signal end 
and coding end, DNA from lymphoblasts was ligated to a linker, and PCR was 
performed using linker primer and oligonucleotide sequences of T-cell receptor or 
antibody genes. Generalized EDSBs can occur anywhere in the genome. Therefore, 
we replaced IRS as a primer instead of T-cell receptor or antibody genes [67, 68]. As 
a result, IRS-EDSB-LMPCR yields two types of amplicons, IRS-EDSB and IRS-IRS 
sequences, and we detected linker sequences that represent EDSB amplicons. In 
brief, IRS-EDSB-LMPCR was performed as follows. First, the oligonucleotide 
linker, EDSB linker, was ligated to high-molecular-weight DNA (HMWDNA) or 
nucleus. Second, real-time quantitative PCR was performed using two PCR prim-
ers. The first was homologous to IRS, and the other had the same sequence as the 
5′ end of the ligation linker. The number of EDSBs could be measured by Taqman 
probe homology to the 3′ end of the ligation linker sequence. The HMWDNA or 
Figure 2. 
DNA methylation possesses a long-range effect in stabilizing the human genome in cis. This diagram represents 
a fraction of the human genome before and after Alu siRNA transfection. While Alu siRNA methylated 
only 10% of Alu loci, Alu siRNA reduced 75% of the 8-OHdG in the entire genome [14]. Therefore, DNA 
methylation possesses a long-range effect in stabilizing the human genome. Blue circles are DNA methylation 
and white circles are unmethylated DNA.
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nucleus served as a source of EDSBs, and the EDSB linker detected and ligated 
EDSBs. The first PCR cycle polymerized DNA from genome-wide distributed IRSs. 
The polymerization through EDSBs generated an EDSB-LMPCR linker template. 
The IRS-EDSB-linker sequences were generated, detected, and quantitated by the 
Taqman probe during PCR cycle (Figure 3) [15].
Common criticism of IRS-EDSB-LMPCR is the possibility of DNA shear-
ing from HMWDNA preparation. However, the characteristics of the DSBs 
generated by DNA preparation are different from RIND-EDSBs. In humans, the 
sequence around RIND-EDSBs is always hypermethylated, whereas methylation 
levels of DSBs from mechanical shearing possess less methylation than RIND-
EDSBs [15]. To prove that the RIND-EDSBs are real, we compared EDSBs from 
linker ligated to HMWDNA and nucleus and found that RIND-EDSBs analyzed 
directly from in situ ligation displayed the same pattern as IRS-EDSB-LMPCR 
from HMWDNA [17]. Therefore, DSBs detected by IRS-EDSB-LMPCR were 
endogenous in origin.
3.2 Phy-RIND-EDSBs are evolutionarily conserved epigenetic marks
Nature has conserved all epigenetic marks by conserving the genes that 
produce epigenetic marks [7]. Epigenetic marks have a specific biologi-
cal role, whether it is gene expression, genomic stability, or interacting with 
DNA. Therefore, the genome distribution of epigenetic markers will not be 
random. Finally, epigenetic marks are usually crucial for cell survival and there-
fore should be ubiquitously present in all cells. To search for genes that produce or 
maintain Phy-RIND-EDSBs, we evaluated RIND-EDSB levels in yeast strains that 
lack functional mutation genes encoding various DNA repair regulators, chroma-
tin formation, endonucleases, topoisomerase, and chromatin-condensing proteins 
[17]. We found low levels of RIND-EDSBs in cells lacking high-mobility group box 
(HMGB) proteins and Sir2. Thus, HMGB proteins and Sir2 play roles in producing 
and maintaining Phy-RIND-EDSBs [17]. Phy-RIND-EDSBs are distributed in the 
genome nonrandomly [18]. In humans, Phy-RIND-EDSBs are localized within 
hypermethylated DNA [15]. In yeast, DNA sequences 5′ end to RIND-EDSBs were 
not random; certain four-nucleotide sequences were more likely to be present 
immediately prior to the breaks. Moreover, RIND-EDSBs were prevented from 
occurring or were never observed following certain four-base combinations 
[18]. RIND-EDSBs were found in yeast and in the human genome, and therefore, 
Phy-RIND-EDSBs are conserved in eukaryotic organisms [15, 17]. In humans, 
RIND-EDSBs were detectable in all cell types and found within the hypermethyl-
ated genome in all phases of the cell cycle [15]. In yeast, we found a very strong 
direct correlation between cell viability and Phy-RIND-EDSB levels (r = 0.94, 
p < 0.0001) [19]. In other words, the more Phy-RIND-EDSBs a cell possesses, 
the better the cell survives [19]. When Phy-RIND-EDSB levels were reduced by 
homothallic switching (HO) endonuclease induction or NHP6A gene deletion, cell 
viability decreased [19]. In conclusion, Phy-RIND-EDSBs are epigenetic markers 
that are important in all eukaryotic cells [19].
Most of the RIND-EDSBs under normal physiologic conditions are not DNA 
damage, signals of the DDR, or precursors of mutations [16]. While sequences 
around human RIND-EDSBs are hypermethylated, γH2AX-binding DNA is hypo-
methylated. Therefore, most RIND-EDSBs are devoid of γH2AX [16]. γH2AX is 
a H2AX molecule that is phosphorylated at serine 139 by the signaling cascade of 
DDR of pathologic DSBs [69]. Most RIND-EDSBs are repaired by a more precise 
ATM-dependent pathway, and therefore, most RIND-EDSBs under normal physi-
ologic conditions are Phy-RIND-EDSBs [16].
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Figure 3. 
IRS-EDSB-LMPCR diagram demonstrating IRS-EDSB-LMPCR. LMPCR linker ligates to EDSB. The 5′ end 
of the LMPCR linker is the same sequence as the PCR primer. The 3′ end of the LMPCR linker is homologous to 
the Taqman probe. The Taqman probe is used for quantitation of EDSBs by real-time PCR. The IRS primer is 
a PCR primer with IRS sequences to polymerize numerous locations of the genome [15].
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nucleus served as a source of EDSBs, and the EDSB linker detected and ligated 
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The polymerization through EDSBs generated an EDSB-LMPCR linker template. 
The IRS-EDSB-linker sequences were generated, detected, and quantitated by the 
Taqman probe during PCR cycle (Figure 3) [15].
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3.3 Phy-RIND-EDSB or youth-DNA-GAP complex
Human Phy-RIND-EDSBs are localized in hypermethylated DNA regions 
and deacetylated histones [15, 16]. Phy-RIND-EDSBs are reduced in cells lacking 
HMGB proteins and Sir2 and NAD-dependent deacetylase [17, 70]. The human Sir2 
homolog, sirtuin 1 (SIRT1), binds to the HMGB1 protein and deacetylates DNMT1 
[71, 72]. Furthermore, HMGB1 possesses deoxyribophosphate lyase activity [73]. 
Therefore, we propose a hypothesis here that HMGB1 cuts DNA to produce Phy-
RIND-EDSBs. SIRT1-bound HMGB1 deacetylates histones, keeping Phy-RIND-
EDSB ends within the heterochromatin to shield them from the DDR signal. Finally, 
the interaction between SIRT1 and DNMT1 or deacetylated histone and DNA 
methylation may be the reason why sequences around human Phy-RIND-EDSBs are 
hypermethylated (Figure 4).
Interestingly, both HMGB1 and Sir2 have other functions that can be related to 
Phy-RIND-EDSBs. HMGB1 is a protein in another physiologic EDSB complex, the 
signal end and coding end of V(D)J recombination [74]. Moreover, yeast lacking the 
NHP6A protein, a type of yeast HMGB, shows increased endogenous DNA damage 
and sensitivity to UV light [75]. Finally, HMGB1 has the ability to bend DNA [76]. 
To prevent DNA torsion, it is reasonable to create Phy-RIND-EDSBs while bending 
DNA. Sir2 can deacetylate the histone, while Phy-RIND-EDSBs are localized in the 
deacetylated histone. Interestingly, Sir2 and SIRT1 are known to prevent the aging 
process [77, 78].
3.4  Spontaneous pathologic RIND-EDSBs and modified ends with insertion at 
the breaks
Independent of DNA replication, EDSB-LMPCR could detect pathologic 
RIND-EDSBs (Path-RIND-EDSBs) as excess EDSBs when DSB repair was inhib-
ited by chemical inhibition or DSB repair gene mutation [19]. When we treated 
G0 yeast cells with caffeine, a DSB repair inhibitor, we observed a spontaneous 
increase in RIND-EDSBs [19]. These excess RIND-EDSBs did not possess the same 
5′ end-sequence-four-base combinations as Phy-RIND-EDSBs odds ratio (OR) > 1 
breaks. Notably, we called four-base combinations that are unlikely to be found 
in Phy-RIND-EDSBs as OR ≤ 1 breaks [18]. Moreover, we also observed that 
the 5′ end sequence downstream of the break did not match with the genomic 
sequence from the first base as reads with modified ends with insertion at the 
breaks (MIBs) [57]. We found that caffeine treatment increased the proportion 
Figure 4. 
Phy-RIND-EDSB or youth-DNA-GAP complex: I hypothesize that the HMGB group initiates Phy-RIND-
EDSB and that HMGB interacts with SIR2 or SIRT1. SIRT1 deacetylates histones and DNMT1, and DNMT1 
methylates DNA. The role of Phy-RIND-EDSB or youth-DNA-GAP is to prevent DNA damage anywhere 
along the same chromosome.
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of MIBs [57]. Therefore, MIBs might be a mechanism that compensates for repair 
defects, such as alternate repair of the DSB pathway, or prevents EDSB ends 
from stimulating DDR. Seven repair defect yeast strains, mec1Δ, mre11Δ, nej1Δ, 
rad51Δ, tel1Δ, yku70Δ, and yku80Δ, were studied. Except for nej1Δ, the percent-
ages of OR ≤ 1 breaks and MIBs were significantly increased in all samples when 
compared to the wild type. We also examined whether there was an association 
between MIBs and types of breaks (OR > 1 breaks and OR ≤ 1 breaks) and found 
that in the wild type, MIBs occurred at OR ≤ 1 breaks. In contrast, in mec1Δ, 
mre11Δ, rad51Δ, tel1Δ, yku70Δ, MIBs occurred at both OR > 1 breaks and OR ≤ 1 
breaks [57]. Therefore, both Phy-RIND-EDSBs and Path-RIND-EDSBs are 
produced in the genome independent of DNA replication. However, most Path-
RIND-EDSBs are immediately repaired, while Phy-RIND-EDSBs are  
retained [57].
3.5  Variation in RIND-EDSB level and reduction in Phy-RIND-EDSBs in aging 
and hypomethylated cells
Path-RIND-EDSBs are spontaneously produced and immediately repaired, while 
Phy-RIND-EDSBs are produced and retained by the Phy-RIND-EDSB complex 
formation process. We observed an increase in RIND-EDSB levels in yeast lacking 
a DSB repair gene, topoisomerase and endonuclease. Analysis of EDSB sequences 
suggested that DSB repair inhibition causes retention of both Phy-RIND-EDSBs 
and Path-RIND-EDSBs. For topoisomerase and endonuclease mutants, we pos-
tulated that Phy-RIND-EDSBs may have redundant roles with topoisomerase and 
endonuclease in stabilizing the genome. Nevertheless, sequence analysis is needed 
to prove this hypothesis. As mentioned earlier, one yeast strain lacking the HMGB 
gene or SIR2 possessed a low level of RIND-EDSBs. Therefore, we hypothesized that 
HMGB and Sir2 play roles in PHY-RIND-EDSB complex formation and retention. 
We observed that three chemicals can alter RIND-EDSB levels. Whereas caffeine 
and vanillin, DSB repair inhibitors, increased RIND-EDSB levels, trichostatin A, a 
histone deacetylase inhibitor, decreased the EDSBs. The reduction in RIND-EDSBs 
by trichostatin A suggested that Phy-RIND-EDSBs are retained within facultative 
heterochromatin. This result is similar to the low level of RIND-EDSBs in yeast 
lacking SIR2.
DDR signals to repair Path-RIND-EDSBs can repair and consequently reduce 
Phy-RIND-EDSBs [19]. The retention of Phy-RIND-EDSBs and the immediate 
repair of Path-RIND-EDSBs led to the finding that the majority of RIND-EDSBs 
under normal physiologic conditions are Phy-RIND-EDSBs and that a reduction 
in RIND-EDSBs in any condition is a reduction in Phy-RIND-EDSBs. In addition 
to gene mutation and histone acetylation, we could reduce RIND-EDSB levels in 
yeast by inducing a Path-RIND-EDSB by HO endonuclease induction [19]. HO 
endonuclease is a site-specific endonuclease that cleaves a site in the MAT locus on 
chromosome III [79]. After induction in nondividing yeast, we observed a sustained 
reduction in RIND-EDSBs for up to 4 days. However, when we induced HO in yeast 
lacking MEC1, a DSB repair protein, the reduction was not observed [19]. These 
experiments suggested that Path-RIND-EDSB production can ignite the global DSB 
repair process, and consequently, the retained Phy-RIND-EDSBs are repaired [19]. 
This mechanism is one possible explanation for the reduction in RIND-EDSBs in 
chronologically aging yeast.
Phy-RIND-EDSB levels in the elderly should be low. We found low levels of 
RIND-EDSBs in chronologically aging yeast and in the human cancer cells, HeLa 
and SW480, which are cervical cancer and colon cancer cell lines, respectively 
[15, 19]. Phy-RIND-EDSBs are localized in hypermethylated genomic regions [15]. 
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rad51Δ, tel1Δ, yku70Δ, and yku80Δ, were studied. Except for nej1Δ, the percent-
ages of OR ≤ 1 breaks and MIBs were significantly increased in all samples when 
compared to the wild type. We also examined whether there was an association 
between MIBs and types of breaks (OR > 1 breaks and OR ≤ 1 breaks) and found 
that in the wild type, MIBs occurred at OR ≤ 1 breaks. In contrast, in mec1Δ, 
mre11Δ, rad51Δ, tel1Δ, yku70Δ, MIBs occurred at both OR > 1 breaks and OR ≤ 1 
breaks [57]. Therefore, both Phy-RIND-EDSBs and Path-RIND-EDSBs are 
produced in the genome independent of DNA replication. However, most Path-
RIND-EDSBs are immediately repaired, while Phy-RIND-EDSBs are  
retained [57].
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and Path-RIND-EDSBs. For topoisomerase and endonuclease mutants, we pos-
tulated that Phy-RIND-EDSBs may have redundant roles with topoisomerase and 
endonuclease in stabilizing the genome. Nevertheless, sequence analysis is needed 
to prove this hypothesis. As mentioned earlier, one yeast strain lacking the HMGB 
gene or SIR2 possessed a low level of RIND-EDSBs. Therefore, we hypothesized that 
HMGB and Sir2 play roles in PHY-RIND-EDSB complex formation and retention. 
We observed that three chemicals can alter RIND-EDSB levels. Whereas caffeine 
and vanillin, DSB repair inhibitors, increased RIND-EDSB levels, trichostatin A, a 
histone deacetylase inhibitor, decreased the EDSBs. The reduction in RIND-EDSBs 
by trichostatin A suggested that Phy-RIND-EDSBs are retained within facultative 
heterochromatin. This result is similar to the low level of RIND-EDSBs in yeast 
lacking SIR2.
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repair of Path-RIND-EDSBs led to the finding that the majority of RIND-EDSBs 
under normal physiologic conditions are Phy-RIND-EDSBs and that a reduction 
in RIND-EDSBs in any condition is a reduction in Phy-RIND-EDSBs. In addition 
to gene mutation and histone acetylation, we could reduce RIND-EDSB levels in 
yeast by inducing a Path-RIND-EDSB by HO endonuclease induction [19]. HO 
endonuclease is a site-specific endonuclease that cleaves a site in the MAT locus on 
chromosome III [79]. After induction in nondividing yeast, we observed a sustained 
reduction in RIND-EDSBs for up to 4 days. However, when we induced HO in yeast 
lacking MEC1, a DSB repair protein, the reduction was not observed [19]. These 
experiments suggested that Path-RIND-EDSB production can ignite the global DSB 
repair process, and consequently, the retained Phy-RIND-EDSBs are repaired [19]. 
This mechanism is one possible explanation for the reduction in RIND-EDSBs in 
chronologically aging yeast.
Phy-RIND-EDSB levels in the elderly should be low. We found low levels of 
RIND-EDSBs in chronologically aging yeast and in the human cancer cells, HeLa 
and SW480, which are cervical cancer and colon cancer cell lines, respectively 
[15, 19]. Phy-RIND-EDSBs are localized in hypermethylated genomic regions [15]. 
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Therefore, cancer genome hypomethylation may explain why RIND-EDSB levels 
in cancer cells were low [15, 27]. We have not reported RIND-EDSB levels in the 
elderly. However, our unpublished data demonstrated results similar to those in 
chronologically aging yeast and in cancer cells.
3.6 Reduction in Phy-RIND-EDSBs augments pathologic EDSB production
To define the molecular mechanism by which the reduction in Phy-RIND-
EDSBs in chronological aging in yeast reduced cell viability and to evaluate the 
consequences of Phy-RIND-EDSB reduction, we analyzed yeast cells with low 
levels of Phy-RIND-EDSBs, including HO endonuclease and nhp6a∆, a high-
mobility group box protein mutant [19]. Very high levels of Path-RIND-EDSBs 
were observed in both strains possessing low levels of Phy-RIND-EDSBs after 
treatment with caffeine, a DSB repair inhibitor. The new Path-RIND-EDSBs were 
not in the same location as Phy-RIND-EDSBs. Therefore, similar to DNA methyla-
tion, Phy-RIND-EDSB stabilizes the genome far beyond the Phy-RIND-EDSB 
complex (Figure 4). These experiments led to my conclusion that the role of 
Phy-RIND-EDSBs is similar to that of EDSBs induced by topoisomerase, which is 
DNA torsion prevention and DNA tension reduction from DNA spinning due to 
any DNA activity, including transcription, replication, and repair. The role of Phy-
RIND-EDSBs can be imagined as gaps in a railroad track that prevent track torsion 
from track expansion by heat. Phy-RIND-EDSB levels decreased in chronologically 
aging yeast, and the reduction was directly correlated with reduced cell viability. 
Therefore, Phy-RIND-EDSBs play a Youth-DNA-GAPs role in preventing Path-
RIND-EDSBs and DNA damage lesions [19]. Moreover, the nhp6a gene is known 
to prevent other types of DNA lesions, such as pyrimidine dimers [75]. Therefore, 
it is reasonable to hypothesize that the scatter distribution of the Phy-RIND-EDSB 
complex prevents all kinds of DNA damage along the length of the whole genome 
(Figure 4).
3.7  DNA repair activity may be compromised in aging cells by a reduction in 
Phy-RIND-EDSBs
A reduction in Phy-RIND-EDSBs during chronological aging may be a cause of 
DNA repair defects in the elderly. DNA repair machinery is known to be compro-
mised and error-prone with age [59, 75]. Numerous studies have found a significant 
decline in all commonly known repair pathway activities with aging, including 
double-strand break repair activities [53–56]. We demonstrated that the reduction 
in the Phy-RIND-EDSB complex will increase the production of DNA damage [19]. 
Therefore, aging cells have to repair DNA damage more often than younger cells. As 
a result, more DNA repair machinery is required for older cells. Consequently, DNA 
repair substrates are consumed more quickly than they are produced, resulting in 
DNA repair defects in the elderly.
4. Conclusion
All evidences described in this chapter suggest that genomic instability in the 
elderly is a vicious cycle of interactive networks among DNA damage, DNA repair, 
DNA demethylation, and reduction in Youth-DNA-GAPs (Figure 5). DNA damage 
occurs spontaneously. Then, the DNA repair process, in addition to repairing DNA 
damage, has consequences of reducing epigenetic marks. While NER demethylates 
DNA, the DSB repair pathway will repair Phy-RIND-EDSBs. DNA demethylation 
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results in global hypomethylation and consequently reduces the homing of Phy-
RIND-EDSBs. The depletion of the Phy-RIND-EDSB complex will then augment 
DNA damage production. Cells need to use many DNA repair substrates to elimi-
nate DNA damage faster than these substrates are produced and eventually lose 
the capability of DNA repair. As a result, aging cells continue to accumulate DNA 
damage and send DDR signals, halting the cell cycle, causing metabolic rewiring, 
and eventually driving cells to enter senescence.
Figure 5. 
Destructive network of aging DNA. DNA damage can occur spontaneously. The base modification repair 
consequence is DNA demethylation, and DSB repair for pathologic DSB will also globally repair Phy-RIND-
EDSBs. Continuous DNA demethylation results in genome-wide hypomethylation, which, together with global 
Phy-RIND-EDSB repair, reduces the Phy-RIND-EDSB complex. A reduction in the Phy-RIND-EDSB complex 
augments DNA damage, and a large amount of DNA damage requires extensive DDR. Cells extensively use 
DDR until the DNA repair machinery is exhausted and defective, at which point, DNA damage accumulates 
and DDR arrests and ages cells.
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mised and error-prone with age [59, 75]. Numerous studies have found a significant 
decline in all commonly known repair pathway activities with aging, including 
double-strand break repair activities [53–56]. We demonstrated that the reduction 
in the Phy-RIND-EDSB complex will increase the production of DNA damage [19]. 
Therefore, aging cells have to repair DNA damage more often than younger cells. As 
a result, more DNA repair machinery is required for older cells. Consequently, DNA 
repair substrates are consumed more quickly than they are produced, resulting in 
DNA repair defects in the elderly.
4. Conclusion
All evidences described in this chapter suggest that genomic instability in the 
elderly is a vicious cycle of interactive networks among DNA damage, DNA repair, 
DNA demethylation, and reduction in Youth-DNA-GAPs (Figure 5). DNA damage 
occurs spontaneously. Then, the DNA repair process, in addition to repairing DNA 
damage, has consequences of reducing epigenetic marks. While NER demethylates 
DNA, the DSB repair pathway will repair Phy-RIND-EDSBs. DNA demethylation 
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results in global hypomethylation and consequently reduces the homing of Phy-
RIND-EDSBs. The depletion of the Phy-RIND-EDSB complex will then augment 
DNA damage production. Cells need to use many DNA repair substrates to elimi-
nate DNA damage faster than these substrates are produced and eventually lose 
the capability of DNA repair. As a result, aging cells continue to accumulate DNA 
damage and send DDR signals, halting the cell cycle, causing metabolic rewiring, 
and eventually driving cells to enter senescence.
Figure 5. 
Destructive network of aging DNA. DNA damage can occur spontaneously. The base modification repair 
consequence is DNA demethylation, and DSB repair for pathologic DSB will also globally repair Phy-RIND-
EDSBs. Continuous DNA demethylation results in genome-wide hypomethylation, which, together with global 
Phy-RIND-EDSB repair, reduces the Phy-RIND-EDSB complex. A reduction in the Phy-RIND-EDSB complex 
augments DNA damage, and a large amount of DNA damage requires extensive DDR. Cells extensively use 
DDR until the DNA repair machinery is exhausted and defective, at which point, DNA damage accumulates 
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